var title_f1_47_1776="Mastectomy closure and drain placement";
var content_f1_47_1776=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 608px\">",
"   <div class=\"ttl\">",
"    Mastectomy closure and drain placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 588px; height: 192px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Closure of the incision, with a Jackson&ndash;Pratt drain exiting the skin of the low axilla and secured externally with a nylon suture. With the drain under the lower ���������ap, it catches the ���������uid dependently.",
"    <br>",
"     (A) The incision with a simple closure of the ellipse.",
"     <br>",
"      (B) With a Y-plasty modi���������cation in the context of those larger individuals who have developed a ridge of tissue extending to the lateral thorax or back secondary to the weight of the breast over time. This closure results in reducing the excess tissue laterally, beyond the breast, which may stick out after closure. Closure of the skin-sparing incisions is not depicted, as it is generally used in the context of collaboration with a plastic surgeon who will reconstruct before closure.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Shaughnessy EA. Simple mastectomy. In: Master Techniques in General Surgery: Breast Surgery, Bland KI, Klimberg SV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"      </div>",
"      <div class=\"contractual\">",
"       <br/>",
"       <a href=\"file://www.lww.com\">",
"        file://www.lww.com",
"       </a>",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1776=[""].join("\n");
var outline_f1_47_1776=null;
var title_f1_47_1777="Short QT interval tutorial";
var content_f1_47_1777=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short QT interval",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 353px; height: 107px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The QT interval (not corrected) in this case is approximately 0.24 seconds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1777=[""].join("\n");
var outline_f1_47_1777=null;
var title_f1_47_1778="Sagittal MRI Sturge-Weber";
var content_f1_47_1778=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sturge-Weber syndrome sagittal MRI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 231px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal MRI of the brain with contrast from a 13-year-old subject with Sturge-Weber syndrome showing a large meningeal capillary-venous malformation (angioma) involving the left hemisphere. Note the contrast enhancement of the gyral pattern and the enlargement of the deep venous system secondary to the increased flow through the extensive lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Bodensteiner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1778=[""].join("\n");
var outline_f1_47_1778=null;
var title_f1_47_1779="Amniotic bands";
var content_f1_47_1779=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amniotic bands",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Image of the extremities shows amniotic bands (arrows) stretching between the extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1779=[""].join("\n");
var outline_f1_47_1779=null;
var title_f1_47_1780="Heart in chronic Chagas disease";
var content_f1_47_1780=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 571px\">",
"   <div class=\"ttl\">",
"    Heart in chronic Chagas disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 551px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longitudinal coronal section of the heart at autopsy (left panel) reveals a typical apical aneurysm; moderate dilation of both ventricles without significant thinning of the left ventricular wall is also found. In the right panel, a closeup of the apical aneurysm shows virtual apposition of endocardium to epicardium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jo&atilde;o Samuel Meira Oliveira, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1780=[""].join("\n");
var outline_f1_47_1780=null;
var title_f1_47_1781="Varicella-zoster immune globulin (human): Pediatric drug information";
var content_f1_47_1781=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Varicella-zoster immune globulin (human): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8326?source=see_link\">",
"    see \"Varicella-zoster immune globulin (human): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?40/7/41076?source=see_link\">",
"    see \"Varicella-zoster immune globulin (human): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16317530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Varizig&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5088784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      VariZIG&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F5124163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Immune Globulin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M.: 125 units;",
"     <b>",
"      Note:",
"     </b>",
"     Most effective if administered as soon as possible after exposure; effectiveness &gt;96 hours after exposure has not been evaluated. High-risk, susceptible patients who are re-exposed &gt;3 weeks after a prior dose of VZIG should receive another full dose; there is no evidence VZIG modifies established varicella-zoster infections.",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F5124173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8326?source=see_link\">",
"      see \"Varicella-zoster immune globulin (human): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Infants, Children, and Adults: I.M.: 125 units/10 kg; maximum dose: 625 units; minimum dose: 125 units; do not give fractional doses;",
"     <b>",
"      Note:",
"     </b>",
"     Most effective if administered as soon as possible after exposure; effectiveness &gt;96 hours after exposure has not been evaluated.  High-risk, susceptible patients who are re-exposed &gt;3 weeks after a prior dose of VZIG should receive another full dose; there is no evidence VZIG modifies established varicella-zoster infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      VZIG Dose Based on Patient Weight:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;10 kg: 125 units = 1 x 125 unit vial",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10.1-20 kg: 250 units = 2 x 125 unit vials",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20.1-30 kg: 375 units = 3 x 125 unit vials",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30.1-40 kg: 500 units = 4 x 125 unit vials",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;40 kg: 625 units = 5 x 125 unit vials or 1 x 625 unit vial",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F16317957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Varizig&reg;: 125 units [contains polysorbate 80; supplied with diluent]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F5088786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5124174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: I.M.:",
"     <b>",
"      DO NOT ADMINISTER I.V. (under restrictions of U.S. IND).",
"     </b>",
"     Bring to room temperature prior to use. For infants and small children, administer I.M. into the anterolateral aspect of the thigh. For adults and older children, administer I.M. into the deltoid muscle or the anterolateral aspect of the thigh. For adults who require large dose volumes, may administer by deep I.M. injection into the upper, outer quadrant of the gluteal muscle. For patients &le;10 kg, administer 1.25 mL at a single site; for patients &gt;10 kg, give no more than 2.5 mL at a single injection site.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F5124170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze. Reconstituted solution can be stored for up to 12 hours at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F) prior to use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F5124164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Provide passive immunity to susceptible, immunocompromised patients after exposure to varicella. Prevention or reduction in severity of infection in pregnant women within 4 days of exposure to varicella zoster virus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Restrict administration to those patients meeting the following criteria:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neoplastic disease (eg, leukemia or lymphoma)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Congenital or acquired immunodeficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immunosuppressive therapy with steroids, antineoplastic agents, radiation, or other immunosuppressive treatment regimens",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Newborn of mother who had onset of chickenpox within 5 days before delivery or within 48 hours after delivery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature (&ge;28 weeks gestation) whose mother has no history of chickenpox",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature (&lt;28 weeks gestation or &le;1000 g) regardless of maternal history",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      One of the following types of exposure to varicella or zoster may warrant VZIG administration in a susceptible patient:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous household contact",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Playmate contact (&gt;1 hour play indoors)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hospital contact (in same 2-4 bed room or adjacent beds in a large ward or prolonged face-to-face contact with an infectious staff member or patient)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immunocompromised adolescents and adults and to other older patients on an individual basis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Age is the most important risk factor for reactivation of varicella zoster; persons &lt;50 years of age have incidence of 2.5 cases per 1000, whereas those 60-79 have 6.5 cases per 1000 and those &gt;80 years have 10 cases per 1000.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5088782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Varicella virus vaccine has been given in error (instead of the indicated varicella immune globulin) to pregnant women exposed to varicella.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F5091360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      U.S. labeling:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Chills, fatigue. headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Injection site pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: DVT, serum sickness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Canadian labeling:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Flushing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Chills, dizziness, fatigue, fever, headache, insomnia, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Dermatitis, rash (including erythematous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Dysgeusia, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Injection site bruising, itching, pain, or tenderness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Myalgia, neck pain",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F5124166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to VZIG, immune globulin, or any component; patients with IgA deficiency;  known immunity to varicella zoster virus (prior infection or immunization).",
"     <b>",
"      Note:",
"     </b>",
"     U.S. CDC guidelines: Healthy and immunocompromised patients [except bone marrow transplant recipients (BMT)] with positive history of varicella infection are considered immune. BMT patients who had varicella infection",
"     <i>",
"      prior to",
"     </i>",
"     transplant are",
"     <b>",
"      not",
"     </b>",
"     considered immune; however, the expanded access protocol does not include use for this indication. BMT patients who develop varicella infection",
"     <i>",
"      after",
"     </i>",
"     transplant",
"     <b>",
"      are",
"     </b>",
"     considered immune. Patients who are fully vaccinated, but later became immunocompromised should be monitored closely; treatment with VZIG is not indicated, but other therapy may be needed if disease occurs.",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5124200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use of VZIG in patients with a bleeding diathesis should be avoided. Not for prophylactic use in immunodeficient patients with history of varicella, unless patient's immunosuppression is associated with bone marrow transplantation; not recommended for nonimmunodeficient patients, including pregnant women, because the severity of chickenpox is much less than in immunosuppressed patients; patients receiving monthly treatments of high-dose intravenous immunoglobulins (100-400 mg/kg) are likely to be protected and probably do not require VZIG if the last dose of IVIG was given in the 3 weeks before exposure",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F5124167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     VZIG is not indicated for prophylaxis or therapy of normal adults who are exposed to or who develop varicella; not indicated for treatment of herpes zoster. Hypersensitivity and anaphylactic reactions can occur; immediate treatment (including epinephrine 1:1000) should be available. Reactions can occur in patients with IgA deficiency or hypersensitivity reactions to human globulin. Product of human plasma; may potentially contain infectious agents which could transmit disease. Screening of donors, as well as testing and/or inactivation or removal of certain viruses, reduces the risk. Infections thought to be transmitted by this product should be reported to the manufacturer (Cangene Corporation 800-768-2304). Thrombotic events have been reported with administration of intravenous immune globulin; use with caution in patients with cardiovascular risk factors. I.M. administration may be preferred in this patient population. Acute renal dysfunction (increased serum creatinine, oliguria, acute renal failure) can rarely occur in patients receiving intravenous immune globulin products; usually within 7 days of use (more likely with products stabilized with sucrose); VariZIG&trade; does not contain sucrose. Use with caution in the elderly, patients with renal disease, diabetes mellitus, volume depletion, sepsis, paraproteinemia, and nephrotoxic medications due to risk of renal dysfunction. Noncardiogenic pulmonary edema has been reported with intravenous administration of immune globulin; monitor for transfusion-related acute lung injury (TRALI). Use caution with pre-existing respiratory conditions. I.M. administration may be preferred in this patient population. Contains polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F5091362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immune Globulins may diminish the therapeutic effect of Vaccines (Live).  Management: Live organism vaccination should be withheld for up to 6 months following immune globulin administration.  Live vaccine given immediately prior to immune globulin may require repeat vaccination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Yellow Fever Vaccine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F16317535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5088791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Endogenous immune globulins cross the placenta. Clinical use of other immunoglobulins suggest that there are no adverse effects on the fetus. Women who do not have evidence of immunity to varicella may be at increased risk of complications if infected during pregnancy. Varicella infection in the mother can also lead to intrauterine infection in the fetus. VZIG is primarily used to prevent maternal complications, not fetal infection (CDC, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13800073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Observe for adverse effects for 20 minutes following administration. The CDC also recommends monitoring for signs and symptoms of varicella infection for 28 days after VZIG administration.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F5124171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The varicella-zoster antibody present in VZIG provides passive immunity to susceptible immunodeficient patients exposed to the varicella-zoster virus by neutralizing the virus.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F5124172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration: 3 weeks",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F5124201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An acceptable alternative to VZIG prophylaxis is to treat varicella, if it occurs, with high-dose I.V. acyclovir. In susceptible children and adults for whom the varicella vaccine is not contraindicated, live varicella virus vaccine can be given within 3 to 5 days after exposure to prevent or modify infection severity. There is no evidence VZIG modifies established varicella-zoster infections.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Varicella-zoster immune globulin (VZIG) was discontinued by the manufacturer. An investigational product (VariZIG) is available under the product's IND application. Investigational Review Board (IRB) approval for this agent should be in place before accessing this product. Eligible patients include pregnant women, immunocompromised patients, neonates, or premature infants in selected situations.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention,&rdquo;",
"      <i>",
"       MMWR",
"      </i>",
"      , 1996, 45(RR-11):1-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/47/1781/abstract-text/8668119/pubmed\" id=\"8668119\" target=\"_blank\">",
"        8668119",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP),",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2007, 56(RR-4):1-40. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/47/1781/abstract-text/17585291/pubmed\" id=\"17585291\" target=\"_blank\">",
"        17585291",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Prevention of Varicella Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP),&rdquo;",
"      <i>",
"       MMWR",
"      </i>",
"      , 1999, 48(RR-6):1-5.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12954 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1781=[""].join("\n");
var outline_f1_47_1781=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317530\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5088784\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124163\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445216\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124173\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317957\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5088786\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124174\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124170\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124164\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5088782\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5091360\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124166\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124200\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124167\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300209\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5091362\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317535\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5088791\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13800073\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124171\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124172\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5124201\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12954\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12954|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8326?source=related_link\">",
"      Varicella-zoster immune globulin (human): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/7/41076?source=related_link\">",
"      Varicella-zoster immune globulin (human): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_47_1782="Lung biopsy in scleroderma ILD";
var content_f1_47_1782=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lung biopsy in scleroderma-associated interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lung biopsy from a patient with scleroderma and a reticular pattern on high resolution CT scan. This later stage of the disease is characterized by fibrosis (stained pink) and tissue destruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Professor B Corrin, Royal Brompton and National Heart Hospital, London, UK.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1782=[""].join("\n");
var outline_f1_47_1782=null;
var title_f1_47_1783="Angiogram cerebellar hemangio";
var content_f1_47_1783=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F55268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F55268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Cerebellar hemangioblastoma: Angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Conventional angiogram of the cerebellar hemangioma pictured in radiograph 1, showing the extensive vascularity and typical tumor blush following contrast injection (left panel). Therapeutic embolization of the feeder vessels lessens potential bleeding complications during surgery. Following therapeutic embolization, the tumor blush is substantially reduced (right panel, red arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eric T Wong, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1783=[""].join("\n");
var outline_f1_47_1783=null;
var title_f1_47_1784="Designer drugs of abuse";
var content_f1_47_1784=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Designer drugs of abuse",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Cynthia C Hoecker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1784/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1784/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/47/1784/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Designer drugs of abuse are synthetic derivatives of federally controlled substances, created by slightly altering the molecular structure of existing drugs and are produced illegally in clandestine laboratories for illicit use [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/1\">",
"     1",
"    </a>",
"    ]. Many of the most popular designer drugs on the street today are amphetamine analogs. Most of these drugs have some psychoactive properties and cause visual disturbances, but they are not true hallucinogens like lysergic acid diethylamide (LSD) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Legislation was passed in the mid-1980s that made it illegal to manufacture, sell, or possess designer drugs in the United States. Despite this legislation, the synthesis, sale, and use of designer drugs remains a significant problem among teenagers and young adults, creating a considerable public health and law enforcement problem [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The common street names and chemical class of the most commonly used designer drugs of abuse are reviewed here. Clinical effects and management of acute intoxication caused by the following drugs of abuse are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cocaine (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=see_link\">",
"       \"Cocaine: Acute intoxication\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ecstasy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"       \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"       \"MDMA (ecstasy) intoxication\", section on 'Management'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Methamphetamine (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H4#H4\">",
"       \"Methamphetamine intoxication\", section on 'Clinical features of overdose'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H9#H9\">",
"       \"Methamphetamine intoxication\", section on 'Management'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Phencyclidine (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link&amp;anchor=H8#H8\">",
"       \"Phencyclidine (PCP) intoxication in children and adolescents\", section on 'Clinical features of overdose'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link&amp;anchor=H24#H24\">",
"       \"Phencyclidine (PCP) intoxication in children and adolescents\", section on 'Management'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"       Ketamine",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=see_link&amp;anchor=H5#H5\">",
"       \"Ketamine poisoning\", section on 'Clinical presentation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=see_link&amp;anchor=H16#H16\">",
"       \"Ketamine poisoning\", section on 'Management'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Opioids (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H13#H13\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H23#H23\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Management of acute toxicity'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     AMPHETAMINE ANALOGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amphetamine analogs are the most popular designer drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/1\">",
"     1",
"    </a>",
"    ]. They are synthesized by attaching various substituents (including methoxy, methyl, halogen, or sulfur) to different positions of the phenyl ring of amphetamine or methamphetamine&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef60505 \" href=\"UTD.htm?41/13/42206\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The most widely used amphetamine analogs include methylenedioxymethamphetamine (MDMA, ecstasy), methamphetamine (ice, crystal), methylenedioxyamphetamine (MDA, the love pill), and methylenedioxyethamphetamine (MDEA, Eve) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/1\">",
"     1",
"    </a>",
"    ]. Piperazine derivatives, such as BZP (benzylpiperazine) and TFMPP (trifluoromethylphenylpiperazine), have similar effects and toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     MDMA (Ecstasy)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharmacology, toxicology, clinical presentation, and management of acute MDMA intoxication are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef57745 \" href=\"UTD.htm?41/60/42956\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H2#H2\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Pharmacology and cellular toxicology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MDMA (methylenedioxymethamphetamine) is one of the most commonly used designer drugs today. Additional street names include \"Ecstasy\", \"E\", \"X-TC\", \"Adam\", \"clarity\", \"Stacy\", \"lover's speed\", &ldquo;molly&rdquo;, and \"essence\" [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/1\">",
"     1",
"    </a>",
"    ]. MDMA has a chemical structure similar to both the hallucinogen mescaline and the stimulant methamphetamine&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef60505 \" href=\"UTD.htm?41/13/42206\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    MDMA usually is sold as a capsule or tablet, but sometimes is found in a powder form that can be snorted or smoked. Single tablets (50 to 200 mg) are sold illicitly for 10 to 30 dollars. Descriptions of MDMA synthesis can be found in scientific journals and on the internet. The proper synthesis requires working knowledge of chemistry techniques; improper techniques are responsible for the impurities found in many preparations sold on the street.",
"   </p>",
"   <p>",
"    Chronic use of MDMA in typical recreational doses can lead to a paranoid psychosis that is clinically indistinguishable from schizophrenia; usually, it is reversible after a prolonged drug-free state [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/6\">",
"     6",
"    </a>",
"    ]. A considerable body of animal data and now at least one human study suggest that MDMA use (possibly in conjunction with cannabis) can lead to cognitive decline in otherwise healthy young people [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Animal studies suggest that axonal degeneration occurs in serotonergic neurons exposed to MDMA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/9\">",
"     9",
"    </a>",
"    ]. One small human study has also found, using single photon emission computed tomographic (SPECT) imaging, that heavy use of MDMA is associated with neurotoxic effects on serotonin neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/10\">",
"     10",
"    </a>",
"    ]. Results of the study further suggested that women may be more susceptible to neurotoxicity than men, and that the neurotoxic changes are reversible, although the sample size and methodologic problems do not permit a strong conclusion on these two points. Nevertheless, loss of serotonin neurons could result in a number of neuropsychiatric disorders in which serotonin has been implicated, including depression, anxiety and panic disorder, and disorders of impulse control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H182726\">",
"    <span class=\"h2\">",
"     MDA",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDA (methylenedioxyamphetamine or 3,4-methylenedioxy- amphetamine) was first synthesized in 1910 and appeared on the streets in the late 1960s (",
"    <a class=\"graphic graphic_figure graphicRef60505 \" href=\"UTD.htm?41/13/42206\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/11\">",
"     11",
"    </a>",
"    ]. It is known as the \"love drug\" or \"love pill\" because of the feelings of intense euphoria and desire to be with others that it produces. MDA effects begin within an hour of ingestion and last up to six hours. MDA currently is classified as a Schedule I hallucinogen by the DEA. Clinical manifestations and treatment are similar to MDMA (ecstasy). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H182733\">",
"    <span class=\"h2\">",
"     MDEA (Eve)",
"    </span>",
"    &nbsp;&mdash;&nbsp;MDEA (methylenedioxyethamphetamine or 3,4-methylene-dioxyethamphetamine), also known as \"Eve\", is a methamphetamine analog that has pharmacologic, psychotropic, and toxic effects similar to those of MDMA, its N-ethyl analog (",
"    <a class=\"graphic graphic_figure graphicRef60505 \" href=\"UTD.htm?41/13/42206\">",
"     figure 1",
"    </a>",
"    ). MDEA is used recreationally throughout Western Europe and in the United States as a sexual stimulant and also is popular at rave parties. It became fashionable after MDMA was restricted by the DEA. Clinical manifestations and treatment are similar to MDMA (ecstasy). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H182740\">",
"    <span class=\"h2\">",
"     PMA (Death)",
"    </span>",
"    &nbsp;&mdash;&nbsp;PMA (paramethoxyamphetamine), also known as \"Death\", is similar to ecstasy in both clinical effects and symptoms of overdose. In one study in Australia, many patients presenting to an emergency department with reported ecstasy poisoning actually had PMA noted in urine drug screens [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition to tachycardia, hyperthermia, coma, seizures, arrhythmias, and a prolonged QT interval that can be seen with ecstasy overdose, findings unique to PMA overdose included hypoglycemia and hyperkalemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"     \"MDMA (ecstasy) intoxication\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Methamphetamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methamphetamine is a sympathomimetic amine that belongs to a class of compounds, the phenethylamines, with a variety of stimulant, anorexiant, euphoric, and hallucinogenic effects. The pharmacology, toxicology, clinical presentation, and management of acute methamphetamine intoxication are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef73681 \" href=\"UTD.htm?20/26/20909\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H2#H2\">",
"     \"Methamphetamine intoxication\", section on 'Pharmacology and cellular toxicology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H4#H4\">",
"     \"Methamphetamine intoxication\", section on 'Clinical features of overdose'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H9#H9\">",
"     \"Methamphetamine intoxication\", section on 'Management'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OPIOID ANALOGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Synthetic analogs of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    also are manufactured by \"basement chemists\" and are used for their heroin-like effects. These derivatives have a much higher potency than does heroin (up to 1000 times more potent) and have been responsible for deaths caused by inadvertent overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/13\">",
"     13",
"    </a>",
"    ]. Other health hazards relating to their use involve impurities from improper synthesis.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is an opiate with 100 times the potency of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    . Its analogs can be injected, smoked, or snorted. Street names for fentanyl analogs include \"Mexican brown\" and \"Persian white\". One of the first recognized designer opioids, alpha-methyl-fentanyl, was popularly known as \"China White\" and appeared in California in 1980 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/14\">",
"     14",
"    </a>",
"    ]. It is estimated to be a thousand times more potent than heroin. Hundreds of fatal overdoses of \"China White\" and other fentanyl derivatives occurred as a result of this increased potency [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/13\">",
"     13",
"    </a>",
"    ]. Three-methyl-fentanyl, another fentanyl analog with 16 times the potency of fentanyl, also has been found in street samples.",
"   </p>",
"   <p>",
"    MPPP (1-methyl-4-phenyl-4-propionoxypiperidine), a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    analog, also known as \"new heroin\" or \"designer heroin\", appeared on the streets in the early 1980s. In 1982, one batch of \"new heroin\" was contaminated through an error in synthesis with a by-product of MPTP (methylphenyltetrahydropyridine) and caused chronic Parkinsonism in many users [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. This incident underscores the dangers of using drugs that are produced in laboratories with no controls for purity or potency.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Clinical effects",
"      </strong>",
"      &ndash; Like heroin and other opioids, synthetic opioid effects include respiratory and CNS depression, analgesia, euphoria, miosis, hypotension, and bradycardia. QRS widening",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      QTc prolongation may be present on EKG in patients who have ingested propoxyphene or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      . Fatalities usually result from respiratory arrest secondary to overdose. Because of the high potency and rapid onset of effects, users with a fatal overdose are often found with the needles still in their arms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H13#H13\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Diagnosis",
"      </strong>",
"      &ndash; Designer opioid intoxication should be suspected in any patient who presents with the signs of classic opioid toxicity but has a urine toxicology screen that is negative for opiates. Toxicology screens that detect opiates may not have the sensitivity to detect low doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      analogs or other synthetic opioids. Specialized forensic testing for designer drugs may be indicated in cases of serious toxicity or death [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Management",
"      </strong>",
"      &ndash; Treatment principles for patients with synthetic opioid toxicity is the same as for other opioids (",
"      <a class=\"graphic graphic_table graphicRef69375 \" href=\"UTD.htm?34/57/35741\">",
"       table 3",
"      </a>",
"      ). Higher total doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      (as high as 10 mg) or a continuous naloxone infusion may be necessary to counteract the higher potency of the synthetic opioids. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link\">",
"       \"Opioid intoxication in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H27#H27\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Naloxone'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PHENCYCLIDINE (PCP), KETAMINE AND RELATED DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analogs of arylhexylamines, a class of drugs that includes phencyclidine (PCP) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , commonly cause dissociative effects, including hallucinations, psychosis, agitation, and violent behavior. Seizures and life-threatening hyperthermia with rhabdomyolysis may occur in severely affected patients. Poisoning with these agents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link\">",
"     \"Phencyclidine (PCP) intoxication in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=see_link\">",
"     \"Ketamine poisoning\"",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     METHCATHINONE ANALOGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methcathinone (&ldquo;Cat&rdquo;), usually available in a powder form, can be snorted, ingested, or injected. It has amphetamine-like stimulatory effects, and users report feelings of euphoria and increased sexual arousal. Methcathinone is a derivative of cathinone, a natural substance found in the leaves of the khat bush (Catha edulis), which grows in the Middle East and East Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/19\">",
"     19",
"    </a>",
"    ]. It is inexpensively and easily manufactured by underground chemists from its precursor, ephedrine. Methcathinone has been widely abused as a designer drug in Russia, where it is known as \"Jeff\". Since 1991, multiple clandestine methcathinone laboratory seizures have occurred in the northwestern, midwestern, and southern United States [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/20\">",
"     20",
"    </a>",
"    ]. Pyrrolidinophenone-derived drugs (eg, PP or R,S-[alpha]-pyrrolidinopropiophenone, MOPPP or R, S-4-methoxy-[alpha]-pyrrolidinopropiophenone) have a similar chemical structure to cathinone and also have amphetamine-like effects although toxicologic information is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/5\">",
"     5",
"    </a>",
"    ]. Manganese in the solution of intravenous methcathinone has been associated with Parkinson disease in a case series from Eastern Europe and Russia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31284353\">",
"    <span class=\"h2\">",
"     Bath salts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bath salts are composed of synthetic cathinones and are analogs of the naturally occurring substance found in the leaves of",
"    <em>",
"     Catha edulis",
"    </em>",
"    (Khat). These agents cause a sympathomimetic syndrome with features that range from pure adrenergic stimulation to a mixed picture of stimulant and hallucinogenic effects (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"     table 4",
"    </a>",
"    ). The clinical features and management of synthetic cathinone intoxication is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/51/20281?source=see_link&amp;anchor=H350266282#H350266282\">",
"     \"Acute amphetamine and synthetic cathinone (&ldquo;bath salt&rdquo;) intoxication\", section on 'Clinical features of overdose'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/51/20281?source=see_link&amp;anchor=H350266375#H350266375\">",
"     \"Acute amphetamine and synthetic cathinone (&ldquo;bath salt&rdquo;) intoxication\", section on 'Management'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H299038\">",
"    <span class=\"h1\">",
"     SYNTHETIC CANNABINOIDS (SPICE, K2)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Synthetic cannabinoids are analogs of naturally occurring chemicals found in marijuana including tetrahydrocannabinol [THC], cannabidiol [CBD] and cannabinol [CBN]. These substances have been detected in herbal products sold in head shops and on the internet and are marketed under many different names, including &ldquo;Spice&rdquo;, &ldquo;K2&rdquo;, &ldquo;Spice Gold&rdquo;, &ldquo;Spice Diamond&rdquo;, &ldquo;Chill Out&rdquo;, and &ldquo;Chill X&rdquo;. Previously they were referred to as &ldquo;legal highs&rdquo; or &ldquo;herbal highs&rdquo;, in reference to their legal status in many countries around the world and their purported natural herbal composition. These compounds are now classified as Class I controlled substances by the US Drug Enforcement Administration and are illegal to possess, distribute, or sell in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. However, illicit use remains significant. As an example, in 2012, up to 11 percent of US high school seniors reported use of synthetic cannabinoids [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &ldquo;Spice&rdquo; products have been marketed in gas stations, convenience stores, and on the internet as incense products and labeled as &ldquo;not for human consumptions&rdquo;. Users ingest or inhale the smoke in the same manner as marijuana and often describe cannabis-like effects after smoking &ldquo;Spice&rdquo; products. In 2008, chemical analysis revealed that the psychoactive effects of &ldquo;Spice&rdquo; and similar products was the result of added synthetic cannabinoids, such as JWH-018, HU-210, CP-47,497, and a long list of others [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/25\">",
"     25",
"    </a>",
"    ]. Many of these cannabinoids and cannabinoid receptor agonists are much more potent than tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN), the most prevalent natural cannabinoids [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1913412\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of &ldquo;Spice&rdquo; use may include reddening of the eyes, tachycardia, anxiety, aggressive behavior, paranoia, hallucinations, inability to speak, dystonia, short-term memory deficits, and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Sympathomimetic effects are more pronounced than that observed after use of marijuana [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/27\">",
"     27",
"    </a>",
"    ]. Prolonged psychosis in a teenager who used &ldquo;Spice&rdquo; in combination with amphetamine analogs has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/28\">",
"     28",
"    </a>",
"    ]. Clinical reports have surfaced demonstrating both addiction syndrome and withdrawal symptoms in habitual users [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/25,29\">",
"     25,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with marijuana use, smoking of synthetic cannabinoid has rarely been associated with myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/30\">",
"     30",
"    </a>",
"    ]. In two small case series, &ldquo;Spice&rdquo; use has also been associated with reversible acute kidney injury necessitating renal replacement therapy in some patients and characterized by acute tubular necrosis and interstitial nephritis on renal biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/27,31\">",
"     27,31",
"    </a>",
"    ]. In some instances, these previously healthy young adults reported smoking a blueberry or bubblegum-flavored synthetic cannabinoid. A unique synthetic cannabinoid, 1-((5-fluoropentyl)-1H-indol-3yl) (2,23,3,-tetramethylcyclopropyl) methanone (also called XLR-11) was found in clinical specimens and product samples from five affected patients treated in different regions of the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/27\">",
"     27",
"    </a>",
"    ]. However, the specific chemical agent responsible for causing renal toxicity is not known. &nbsp;",
"   </p>",
"   <p>",
"    Standard toxicology tests (rapid urine immunoassays) currently employed to detect naturally occurring THC are not able to detect these many synthetic cannabinoid-like substances, thus allowing &ldquo;Spice&rdquo; users to escape easy detection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1913419\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of overdose or any adverse effects from the synthetic cannabinoids primarily consists of supportive care (eg, placement in a quiet, dim, calm environment), long-acting benzodiazepines (eg, intramuscular or oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    ) for agitation, and intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    for dystonia. The duration of acute synthetic cannabinoid toxicity depends upon the exposure dose, but, in one small case series, ranged from 4 to less than 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link&amp;anchor=H4#H4\">",
"     \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\", section on 'Treatment of intoxication'",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1913618\">",
"    <span class=\"h1\">",
"     METHAQUALONE ANALOGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methaqualone (popularly known as \"Quaalude\") was introduced as a sleeping pill in 1965, but was reclassified as a schedule I substance in 1984. The synthesis of methaqualone is not difficult; at least two of its analogs, mecloqualone and nitromethaqualone, have been synthesized in clandestine laboratories in the United States and are sold for their psychoactive effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/32\">",
"     32",
"    </a>",
"    ]. Toxic effects include ataxia, lethargy, obtundation, and muscle hyperactivity. Treatment of overdose is supportive. Oral use of methaqualone has declined, but smoking of methaqualone in combination with marijuana is a common abuse pattern in South Africa, other parts of Africa, and India. Methaqualone has the potential to induce a barbiturate-type dependence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OTHER HERBAL DESIGNER DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A liquid product called \"green hornet\" is promoted on the internet and sold in stores as an herbal version of ecstasy. This product contains",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    , among other ingredients. The FDA has issued a warning to consumers not to purchase or use green hornet, or any other substances that are marketed as \"safe\" versions of illicit drugs. These products may cause adverse reactions, including seizures, tachycardia, and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other brands of \"herbal ecstasy\" have different compositions, some containing caffeine and kava kava, and others ephedra [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. The adverse effects of these products vary depending upon the composition, but may include hypertension, tachydysrhythmias, myocardial infarctions, cerebrovascular accidents, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1784/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H536472\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following resources are available for clinicians managing patients intoxicated with designer drugs of abuse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Regional poison control centers often are often among the first resources to become aware of new patterns of designer drug use and toxicity. The United States Poison Control Network can be accessed at 1-800-222-1222. A list of international poison centers is available through the World Health Organization at",
"      <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"       www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The White House Office of National Drug Control Policy maintains a database of street terms at the following website:",
"      <a class=\"external\" href=\"file://www.whitehousedrugpolicy.gov/index.html\">",
"       file://www.whitehousedrugpolicy.gov/index.html",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5588843\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Designer drugs are synthetic derivatives of federally controlled substances, created by slightly altering the molecular structure of existing drugs, and are produced illegally in clandestine laboratories for illicit use. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Amphetamine analogs are the most commonly used designer drugs of abuse. Among these, methylenedioxymethamphetamine (MDMA, &ldquo;Ecstasy&rdquo;) and methamphetamine (&ldquo;Ice&rdquo;, &ldquo;crystal Meth&rdquo;) are the most widely used. Methylenedisoxyamphetamine (MDA, &ldquo;the love pill&rdquo;), methylenedioxymethamphetamine (MDEA, &ldquo;Eve&rdquo;), and piperazine derivatives, such as BZP (benzylpiperazine) and TFMPP (trifluoromethylphenyl piperazine) have similar effects and toxicity. The clinical presentation and management of acute intoxication with amphetamine analogs is discussed separately. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Amphetamine analogs'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H4#H4\">",
"       \"MDMA (ecstasy) intoxication\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link&amp;anchor=H13#H13\">",
"       \"MDMA (ecstasy) intoxication\", section on 'Management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H4#H4\">",
"       \"Methamphetamine intoxication\", section on 'Clinical features of overdose'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=see_link&amp;anchor=H9#H9\">",
"       \"Methamphetamine intoxication\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Synthetic analogs of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      (eg, alpha-methyl-fentanyl or &ldquo;China White&rdquo;) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      also are manufactured by \"basement chemists\" and are used for their heroin-like effects. These derivatives have a much higher potency than does heroin (up to a thousand times more potent) and have been responsible for deaths caused by inadvertent overdose. Treatment principles for patients with synthetic opioid toxicity are the same as for other opioids. Higher total doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      (as high as 10 mg) or a continuous naloxone infusion may be necessary to counteract the higher potency of the synthetic opioids. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Opioid analogs'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link\">",
"       \"Opioid intoxication in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H27#H27\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Naloxone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Analogs of arylhexylamines, a class of drugs that includes phencyclidine (PCP) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      , commonly cause dissociative effects including hallucinations, psychosis, agitation, and violent behavior. Seizures and life-threatening hyperthermia with rhabdomyolysis may occur in severely affected patients. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Phencyclidine (PCP), ketamine and related drugs'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link&amp;anchor=H8#H8\">",
"       \"Phencyclidine (PCP) intoxication in children and adolescents\", section on 'Clinical features of overdose'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link&amp;anchor=H24#H24\">",
"       \"Phencyclidine (PCP) intoxication in children and adolescents\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Methcathinone (&ldquo;Cat&rdquo;), usually available in a powder form, can be snorted, ingested, or injected. It has amphetamine-like stimulatory effects, and users report feelings of euphoria and increased sexual arousal. Methcathinone is a derivative of cathinone, a natural substance found in the leaves of the khat bush (Catha edulis), which grows in the Middle East and East Africa. Bath salts are composed of synthetic cathinones and are analogs of the naturally occurring substance found in the leaves of",
"      <em>",
"       Catha edulis",
"      </em>",
"      (Khat). These agents cause a sympathomimetic syndrome with features that range from pure adrenergic stimulation to a mixed picture of stimulant and hallucinogenic effects (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Methcathinone analogs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H31284353\">",
"       'Bath salts'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/51/20281?source=see_link\">",
"       \"Acute amphetamine and synthetic cathinone (&ldquo;bath salt&rdquo;) intoxication\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Synthetic cannabinoids (eg, &ldquo;Spice&rdquo; or &ldquo;K2&rdquo;) are potent analogs of naturally occurring chemicals found in marijuana including tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN). Clinical effects include reddening of the eyes, tachycardia, anxiety, aggressive behavior, paranoia, hallucinations, inability to speak, dystonia, short-term memory deficits, and seizures. Psychosis, myocardial infarction, and acute kidney injury have also been rarely described. Treatment is supportive. (See",
"      <a class=\"local\" href=\"#H299038\">",
"       'Synthetic cannabinoids (Spice, K2)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1913412\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1913419\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other designer drugs include analogs of methaqualone (&ldquo;Quaalude&rdquo;) and herbal products. (See",
"      <a class=\"local\" href=\"#H1913618\">",
"       'Methaqualone analogs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Other herbal designer drugs'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/1\">",
"      Christophersen AS. Amphetamine designer drugs - an overview and epidemiology. Toxicol Lett 2000; 112-113:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/2\">",
"      Beebe DK, Walley E. Substance abuse: the designer drugs. Am Fam Physician 1991; 43:1689.",
"     </a>",
"    </li>",
"    <li>",
"     https://dawninfo.samhsa.gov/default.asp (Accessed on January 25, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/4\">",
"      Wood DM, Dargan PI, Button J, et al. Collapse, reported seizure--and an unexpected pill. Lancet 2007; 369:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/5\">",
"      Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit 2004; 26:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/6\">",
"      Buchanan JF, Brown CR. 'Designer drugs'. A problem in clinical toxicology. Med Toxicol Adverse Drug Exp 1988; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/7\">",
"      Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, et al. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 2000; 68:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/8\">",
"      Zakzanis KK, Young DA. Memory impairment in abstinent MDMA (\"Ecstasy\") users: a longitudinal investigation. Neurology 2001; 56:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/9\">",
"      Rattray M. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem 1991; 26:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/10\">",
"      Reneman L, Booij J, de Bruin K, et al. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001; 358:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/11\">",
"      Poklis A, Mackell MA, Drake WK. Fatal intoxication from 3,4-methylenedioxyamphetamine. J Forensic Sci 1979; 24:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/12\">",
"      Ling LH, Marchant C, Buckley NA, et al. Poisoning with the recreational drug paramethoxyamphetamine (\"death\"). Med J Aust 2001; 174:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/13\">",
"      Hibbs J, Perper J, Winek CL. An outbreak of designer drug--related deaths in Pennsylvania. JAMA 1991; 265:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/14\">",
"      Brittain JL. China white: the bogus drug. J Toxicol Clin Toxicol 1982; 19:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/15\">",
"      Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985; 35:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/16\">",
"      Davis GC, Williams AC, Markey SP, et al. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1979; 1:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/17\">",
"      Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/18\">",
"      Wong SC, Curtis JA, Wingert WE. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J Forensic Sci 2008; 53:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/19\">",
"      Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int 2005; 153:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/20\">",
"      Calkins RF, Aktan GB, Hussain KL. Methcathinone: the next illicit stimulant epidemic? J Psychoactive Drugs 1995; 27:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/21\">",
"      Stepens A, Logina I, Liguts V, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008; 358:1009.",
"     </a>",
"    </li>",
"    <li>",
"     Chemicals used in \"Spice\" and \"K2\" type products now under federal control and regulation. Springfield, VA:  US Drug Enforcement Administration; March 1, 2011. www.justice.gov/dea/pubs/pressrel/pr030111.html (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     Congress agrees to add 26 synthetic drugs to Controlled Substances Act. Drug Enforcement Administration Public Affairs, June 19, 2012. file://www.justice.gov/dea/pubs/pressrel/synthetic-drugs_index.html (Accessed on January 15, 2013).",
"    </li>",
"    <li>",
"     Monitoring the Future survey. Overview of findings 2012. National Institute on Drug Abuse. file://www.drugabuse.gov/related-topics/trends-statistics/monitoring-future/monitoring-future-survey-overview-findings-2012 (Accessed on January 15, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/25\">",
"      Vardakou I, Pistos C, Spiliopoulou Ch. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 2010; 197:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/26\">",
"      Cohen J, Morrison S, Greenberg J, Saidinejad M. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics 2012; 129:e1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/27\">",
"      Centers for Disease Control and Prevention (CDC). Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/28\">",
"      Thornton SL, Lo J, Clark RF, et al. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin Toxicol (Phila) 2012; 50:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/29\">",
"      Lindigkeit R, Boehme A, Eiserloh I, et al. Spice: a never ending story? Forensic Sci Int 2009; 191:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/30\">",
"      Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 2011; 128:e1622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/31\">",
"      Bhanushali GK, Jain G, Fatima H, et al. AKI Associated with Synthetic Cannabinoids: A Case Series. Clin J Am Soc Nephrol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/32\">",
"      van Zyl EF. A survey of reported synthesis of methaqualone and some positional and structural isomers. Forensic Sci Int 2001; 122:142.",
"     </a>",
"    </li>",
"    <li>",
"     FDA warns consumers not to purchase green hornet promoted as herbal version of ecstasy. FDA News. www.fda.gov/bbs/topics/NEWS/2004/NEW01026.html.",
"    </li>",
"    <li>",
"     file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108277.htm (Accessed on September 15, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/35\">",
"      Yates KM, O'Connor A, Horsley CA. \"Herbal Ecstasy\": a case series of adverse reactions. N Z Med J 2000; 113:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/36\">",
"      Doyon S. The many faces of ecstasy. Curr Opin Pediatr 2001; 13:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1784/abstract/37\">",
"      Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J Neurol Sci 2004; 217:55.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6500 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.150-851E2265C2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1784=[""].join("\n");
var outline_f1_47_1784=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5588843\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      AMPHETAMINE ANALOGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MDMA (Ecstasy)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H182726\">",
"      MDA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H182733\">",
"      MDEA (Eve)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H182740\">",
"      PMA (Death)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Methamphetamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OPIOID ANALOGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PHENCYCLIDINE (PCP), KETAMINE AND RELATED DRUGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      METHCATHINONE ANALOGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31284353\">",
"      Bath salts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H299038\">",
"      SYNTHETIC CANNABINOIDS (SPICE, K2)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1913412\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1913419\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1913618\">",
"      METHAQUALONE ANALOGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OTHER HERBAL DESIGNER DRUGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H536472\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5588843\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6500\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6500|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/13/42206\" title=\"figure 1\">",
"      Designer drugs structure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6500|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/60/42956\" title=\"table 1\">",
"      MDMA-ecstasy-intoxication - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/26/20909\" title=\"table 2\">",
"      Methamphetamine intoxication in adults - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/57/35741\" title=\"table 3\">",
"      Opioid intoxication in children and adolescents - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/6/44140\" title=\"table 4\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/51/20281?source=related_link\">",
"      Acute amphetamine and synthetic cathinone (&ldquo;bath salt&rdquo;) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=related_link\">",
"      Cannabis use disorders: Treatment, prognosis, and long-term medical effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=related_link\">",
"      Ketamine poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=related_link\">",
"      MDMA (ecstasy) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/29/474?source=related_link\">",
"      Methamphetamine intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=related_link\">",
"      Opioid intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=related_link\">",
"      Phencyclidine (PCP) intoxication in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_47_1785="Infections due to Trichosporon species and Blastoschizomyces capitatus";
var content_f1_47_1785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Infections due to Trichosporon species and Blastoschizomyces capitatus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Gary M Cox, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1785/contributors\">",
"     John R Perfect, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1785/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/47/1785/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trichosporon species and Blastoschizomyces capitatus are related fungi and are rare causes of invasive infection in humans. Trichosporon spp can be found as a constituent of normal flora but can also cause both superficial and invasive infections in humans. Invasive disease due to Trichosporon spp, called trichosporonosis, occurs almost exclusively in immunocompromised hosts, appears to be increasing in frequency, and is usually fatal. This fungus also causes a characteristic infection of hair shafts called white piedra.",
"   </p>",
"   <p>",
"    The mycology, epidemiology, and clinical infections caused by both Trichosporon spp and the related fungus, Blastoschizomyces capitatus, will be reviewed here. Blastoschizomyces capitatus has also been called Geotrichum capitatus and the teleomorph has been called Dipodascus capitatus, but in this topic, we will stay with the nomenclature of Blastoschizomyces.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MYCOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mycology of Trichosporon spp is extremely complicated because the designation refers to a heterogeneous group of organisms. The heterogeneity results from the absence of simple methods to distinguish between the species in the clinical microbiology laboratory; thus, multiple members of the genus Trichosporon were previously categorized together under the name T. beigelii. With the use of modern molecular biological techniques, some mycologists have proposed a rearrangement of the genus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The proposed names for the six main species associated with human infection are T. asahii, T. asteroides, T. cutaneum, T. inkin, T. mucoides, and T. ovoides [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The following disease associations have been observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T. asahii and T. mucoides are associated with systemic infection; T. asahii is more common than T. mucoides",
"     </li>",
"     <li>",
"      T. inkin and T. ovoides are associated with white piedra, affecting hair shafts; T. ovoides with infection of the hair of the scalp and T. inkin with infection of the pubic hair",
"     </li>",
"     <li>",
"      T. asteroides and T. cutaneum are associated with superficial skin lesions",
"     </li>",
"     <li>",
"      T. ovoides has been implicated in a few cases of systemic infection [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A novel member of the genus, T. mycotoxinivorans, has been described as a pulmonary pathogen with an apparent predilection for patients with cystic fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Members of the genus Trichosporon are characterized by the formation of arthroconidia, blastoconidia, hyphae, and pseudohyphae. The genus Trichosporon is closely related to Cryptococcus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. These two fungi share some antigens, and cross-reactivity with the cryptococcal polysaccharide latex agglutination assay can be seen in patients with trichosporonosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/9\">",
"     9",
"    </a>",
"    ]. Trichosporon do not ferment carbohydrates but can assimilate various complex sugars. There is no sexual state known for the genus.",
"   </p>",
"   <p>",
"    Isolation of this fungus from clinical specimens is relatively easy since it grows rapidly on almost all standard fungal media. Colonies usually appear as ivory to beige and moist with radiating furrows over time. Microscopic examination of all isolates shows nonbranching, septate, hyaline hyphae that disarticulate to form arthroconidia. Pseudohyphae and blastoconidia can also be seen, but the presence of annelloconidia, a specialized conidial structure, should suggest the identification of Blastoschizomyces capitatus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In clinical specimens, a yeast-like organism that is urease-positive and forms arthroconidia can be presumptively identified as Trichosporon spp. The identification can then be confirmed with tests of carbohydrate assimilation using commercially available kits. Distinguishing among the proposed species is not currently performed in most clinical laboratories, but guidelines for doing so have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blastoschizomyces capitatus can easily be mistaken for Trichosporon spp because the microscopic appearance is similar. Similar to the Trichosporon species, B. capitatus grows quickly on most mycologic media. Colonies are white, can be smooth or wrinkled, and aerial mycelia can be visible after several days of growth. Microscopically, there are septate, branching hyphae that disarticulate to form arthroconidia. Some mycologists have proposed a reclassification of this organism as Geotrichum capitatum, and this name may appear in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/11\">",
"     11",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The presence of annelloconidia distinguishes B. capitatus from Trichosporon spp morphologically [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/10\">",
"     10",
"    </a>",
"    ]. Another important distinguishing factor is the urease test; all Trichosporon species are urease positive, and B. capitatus is always urease negative. B. capitatus is classified as an ascomycete based upon the production of asci by the teleomorph [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both Trichosporon spp and B. capitatus are found in nature, predominantly in soil. There does not appear to be any association with animals, although these fungi have been cultured from animal droppings.",
"   </p>",
"   <p>",
"    Humans can be colonized with Trichosporon spp and B. capitatus. Mucosal surfaces, stool, sputum and hair have all been reported as sites of colonization. Rates of colonization vary from 1 to 3 percent in patients admitted to general hospital wards [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. However, higher rates have been reported in other patient populations. A study of inguinal skin scrapings from asymptomatic outpatient volunteers in Houston showed Trichosporon colonization rates of 12.4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/15\">",
"     15",
"    </a>",
"    ]. Another study, done in a Danish sexually transmitted diseases clinic, found rectal colonization rates with Trichosporon spp of 13 percent in male homosexuals and 2.5 percent in male heterosexuals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Superficial infections due to Trichosporon spp occur primarily in immunocompetent patients in tropical climates. Some temperate areas, especially the southeastern United States, also have a relatively high prevalence of these superficial infections. White piedra, especially involving the genital area, appears to be most commonly found in young men [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. These superficial infections appear to be sporadic and probably result from asymptomatic carriage of the organism in the hair and skin. Person-to-person spread of superficial Trichosporon spp infections does not occur; poor personal hygiene",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low socioeconomic status are not known risk factors.",
"   </p>",
"   <p>",
"    Trichosporon spp have been implicated as a cause of hypersensitivity pneumonitis in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/18\">",
"     18",
"    </a>",
"    ]. It appears that individuals, perhaps with an underlying genetic predisposition, can react to Trichosporon antigens with a resulting pneumonitis. When rigorous efforts were made to eliminate the organism from the homes of affected patients, the incidence of the disease decreased. It is unclear whether this entity exists outside of Japan.",
"   </p>",
"   <p>",
"    Invasive trichosporonosis occurs almost exclusively in immunocompromised patients. The majority of cases have been seen in patients with hematologic malignancies, often in the setting of neutropenia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/5,11,19,20\">",
"     5,11,19,20",
"    </a>",
"    ]. Other reported risk factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      AIDS [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Extensive burns [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intravenous catheters [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/20,24-26\">",
"       20,24-26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Glucocorticoid treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Heart valve surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many patients have been shown to carry Trichosporon spp prior to the diagnosis of trichosporonosis, and it is therefore likely that endogenous flora are the source for infection. The culture of one of these fungi from a sterile body site must always be regarded as serious. Mucosal cultures growing either Trichosporon spp or B. capitatus, by contrast, can represent colonization and need to be interpreted in the clinical context. It is unclear if surveillance cultures positive for these fungi in immunocompromised patients assist in predicting subsequent infection. There have been pseudoinfections due to Trichosporon spp as a result of improperly sterilized endoscopes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. There have also been hospital outbreaks of trichosporonosis in immunocompromised hosts, and therefore careful adherence to infection control practices will be paramount to protect patients at risk for invasive disease caused by Trichosporon spp [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blastoschizomyces capitatus has only been described as a systemic pathogen, and the affected patients have had some underlying immunocompromising condition, usually neutropenia. The number of reported cases is quite small, most occurring in Italy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/11\">",
"     11",
"    </a>",
"    ]. Cardiac valve replacement in immunocompromised patients has also led to disseminated infection with this fungus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In white piedra, Trichosporon spp begins to grow just beneath the cuticle of hairs shafts. Growth continues outside the hair shaft and a nodule is formed. These nodules can easily be pulled off of the hair but, when left in place, the hair shaft becomes weakened and breaks at the site of the nodule [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/17\">",
"     17",
"    </a>",
"    ]. There are suggestions that strains of Corynebacterium can enhance the growth of Trichosporon spp and may play a synergistic role in white piedra [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most invasive Trichosporon spp infections probably start with colonization of mucosal or cutaneous surfaces, with a break in the integrity of the surface subsequently seeding the bloodstream. Such breaks may be secondary to chemotherapy-induced epithelial damage or intravascular catheters. Antibiotics probably increase the incidence and extent of colonization and may play a role in increasing the risk of human infections.",
"   </p>",
"   <p>",
"    In some cases of localized infection, the fungus may have seeded the site of infection directly. In patients with prosthetic valve endocarditis caused by Trichosporon spp, for example, there may have been direct infection of the prosthesis during the operative procedure rather than fungemia seeding the valve [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/27\">",
"     27",
"    </a>",
"    ]. Other examples that may have resulted from direct inoculation of the fungus include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Peritonitis in chronic ambulatory peritoneal dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/33-35\">",
"       33-35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Wound infections [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Meningitis following a myelogram [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Endophthalmitis after cataract surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In vitro studies have shown that Trichosporon isolates are much more resistant to phagocytosis by neutrophils and monocytes than are isolates of C. albicans [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Pretreatment with colony-stimulating factors and gamma-interferon did not enhance fungal killing by neutrophils but did increase killing by monocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In experimental murine infections, intravenous injection of Trichosporon spp arthroconidia results in multiple focal abscesses throughout the body, but especially in the kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/41\">",
"     41",
"    </a>",
"    ]. Histologic inspection of lesions from both experimental and human infections shows that the formation of hyphae may assist in the invasion of tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/42\">",
"     42",
"    </a>",
"    ]. Emboli consisting of hyphae are frequently found occluding small blood vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/42\">",
"     42",
"    </a>",
"    ]. Many of the lesions in trichosporonosis are probably due to infarcts resulting from angioinvasive foci of Trichosporon spp.",
"   </p>",
"   <p>",
"    Little is known about possible virulence traits in Trichosporon spp. Virulence factors such as toxins, special adherence properties, or components that allow the organism to evade the host's immune system have not yet been found. A cell wall antigen with similarities to the glucuronoxylomannan of C. neoformans has been postulated to be a potential virulence factor [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As already mentioned, Trichosporon spp can cause both superficial and invasive infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Superficial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with white piedra are usually asymptomatic, and only seek medical attention because of the grossly visible nodules on the affected hair. Pruritus or pain at the involved site are occasional complaints. The nodules are usually soft, pasty, and ivory colored. They are about 0.5 mm in size but can coalesce to blanket several millimeters of the hair shaft. Genital and facial hair are more often involved than the scalp and torso.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Invasive infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive infections due to T. asahii can be divided into disseminated and localized forms. The disseminated form is more common and, as mentioned above, usually occurs in neutropenic patients. The patient typically has an acute febrile illness that progresses rapidly to multiorgan failure.",
"   </p>",
"   <p>",
"    Patients with pulmonary involvement can have dyspnea and a cough productive of scant, bloody sputum [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/44\">",
"     44",
"    </a>",
"    ]. Chest radiographs usually show diffuse infiltrates with an alveolar pattern. Lobar infiltrates, reticulonodular infiltrates, and cavitation have also been observed. Patients with renal involvement usually have microscopic hematuria and proteinuria and progress to renal failure. Involvement of the kidneys has been nearly a universal finding in autopsies of patients with disseminated trichosporonosis.",
"   </p>",
"   <p>",
"    Skin lesions are seen in about one-third of patients with disseminated trichosporonosis. The cutaneous manifestations include erythematous papules on the trunk and extremities that can sometimes form bullae [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/42,45,46\">",
"     42,45,46",
"    </a>",
"    ]. Over time, the papules can develop central necrosis and appear as eschars.",
"   </p>",
"   <p>",
"    Some patients who have recovered from their neutropenia and responded to antifungal drugs have presented with a chronic disseminated form of trichosporonosis that is similar to chronic hepatosplenic candidiasis. The few patients reported with this syndrome have had multiple lesions in the liver and spleen associated with fever and elevated serum alkaline phosphatase concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10071?source=see_link\">",
"     \"Hepatosplenic candidiasis (chronic disseminated candidiasis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Invasive Trichosporon spp infections less commonly can be confined to a single organ. The heart valves, central nervous system (CNS), peritoneum, and surgical wounds have all been described as involved sites in the absence of known infection elsewhere. Most of the cases of endocarditis due to Trichosporon spp have involved prosthetic valves [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/27,28,47\">",
"     27,28,47",
"    </a>",
"    ]. However, there have been cases of native valve endocarditis in injection drug users. Valvular vegetations in trichosporon endocarditis tend to be large and bulky as with other forms of fungal endocarditis. These vegetations have a predilection to embolize and cause sudden ischemic events, especially in the lower limbs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/27,47\">",
"     27,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases of CNS infection due to Trichosporon spp, the predominant symptoms are headache, nausea, vomiting, and fever [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/37,48\">",
"     37,48",
"    </a>",
"    ]. Peritonitis with Trichosporon spp, as a complication of chronic ambulatory peritoneal dialysis, has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. There are also increasing reports of bone involvement during dissemination of these fungi and in particular, spine involvement such as spondylodiscitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disseminated infections due to B. capitatus present in a fashion similar to those due to Trichosporon spp. Affected patients present with the sudden onset of fever and rapidly develop pulmonary abnormalities, hypotension, and renal failure. Some have had skin lesions with necrotic papules, and some have had CNS involvement with abscesses and meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455289667\">",
"    <span class=\"h2\">",
"     Superficial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of white piedra is suggested by the characteristic nodules on the shafts of affected hairs. Examination of these nodules mounted on a slide with 10 percent potassium hydroxide shows septate hyphae with arthroconidia. Cultures of the nodules will grow Trichosporon spp in a few days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455289674\">",
"    <span class=\"h2\">",
"     Invasive infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In disseminated Trichosporon spp infections, cultures of blood, urine, sputum [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/44\">",
"     44",
"    </a>",
"    ], cerebrospinal fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/48\">",
"     48",
"    </a>",
"    ], and tissue have all yielded the fungus. Blood cultures are frequently positive in disseminated infection. Culture and histopathology of skin lesions have also been helpful in establishing the diagnosis in disseminated infections. Skin biopsies show dermal invasion by hyphae and arthroconidia, and some have shown thromboembolic vasculitis due to the fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bronchoscopy with alveolar lavage cultures can yield Trichosporon spp in patients with pneumonitis, and urine cultures have been positive in some cases of disseminated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/44\">",
"     44",
"    </a>",
"    ]. Again, it must be emphasized that cultures of Trichosporon spp isolated from sputum or urine may represent colonization rather than infection. However, in a neutropenic host, the culture of this organism from any specimen should be taken seriously and prompt further evaluation.",
"   </p>",
"   <p>",
"    The diagnosis of disseminated trichosporonosis is occasionally suggested by a positive Cryptococcus neoformans polysaccharide antigen assay due to cross-reactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/9\">",
"     9",
"    </a>",
"    ]. There have, however, been cases of disseminated trichosporonosis with negative cryptococcal antigen assays [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/23\">",
"     23",
"    </a>",
"    ]; as a result, a negative test does not exclude trichosporonosis. Cerebrospinal fluid cryptococcal antigen assay, which was positive in one patient with meningitis caused by Trichosporon spp, may also be useful [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood cultures are positive in most cases of B. capitatus infection and establish the diagnosis of disseminated disease. Cultures of urine, sputum and CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/50\">",
"     50",
"    </a>",
"    ] also may be positive in this setting. Cultures of skin biopsies appear to be positive less often in disseminated B. capitatus infections than in trichosporonosis. There are no specific serologic tests for this fungus, and there is no cross-reactivity with cryptococcal polysaccharide antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Superficial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of white piedra is best accomplished by shaving off all the hair in the affected areas and then applying a topical azole antifungal. The most commonly used regimen is 2 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    shampoo for 30 to 60 seconds once daily for several months, with the duration depending on the treatment response. For areas in which a shampoo might be irritating (eg, eyebrows, eyelashes), daily application of an azole antifungal cream for several months is an alternative. For the rare individual allergic to azoles, 6 percent precipitated sulfur in white petrolatum or 2 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/49/34579?source=see_link\">",
"     selenium sulfide",
"    </a>",
"    foam may be substituted. If an individual refuses to shave the affected area, oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    (100 mg once daily for two to four months) should be added to the topical therapy.",
"   </p>",
"   <p>",
"    Follow-up cultures are not routinely recommended but, when performed, they frequently remain positive despite clinical cure of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Invasive infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of invasive infections due to either Trichosporon spp or B. capitatus is extremely difficult because of the profound immunosuppression and severe underlying diseases present in most infected patients. The optimal antifungal agent and duration of therapy are not known. Tentative recommendations can be made based on in vitro susceptibility data (",
"    <a class=\"graphic graphic_table graphicRef71985 \" href=\"UTD.htm?29/2/29742\">",
"     table 1",
"    </a>",
"    ) and clinical experience.",
"   </p>",
"   <p>",
"    In vitro susceptibility studies have shown that these two fungi are relatively resistant to most antifungal agents. Minimum inhibitory concentrations (MIC) to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    have ranged from 0.065",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    to &gt;4",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/2,19,44,51,52\">",
"     2,19,44,51,52",
"    </a>",
"    ]. Strains of Trichosporon spp have been found to be inhibited, but not killed, by the concentrations of amphotericin B achievable in human serum [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The azole drugs",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/60/33737?source=see_link\">",
"     posaconazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    have shown activity against Trichosporon spp and B. capitatus in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/2,11,19,44,48,51-54\">",
"     2,11,19,44,48,51-54",
"    </a>",
"    ]. Some authors have recommended that voriconazole be considered the drug of choice for these infections [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/11,53,55\">",
"     11,53,55",
"    </a>",
"    ]. However, as with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , the achievable serum levels of these agents only result in inhibition rather than killing of these fungi. Breakthrough infection has been described in patients receiving prophylactic amphotericin B, fluconazole, and voriconazole [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/20\">",
"     20",
"    </a>",
"    ]. In one animal model of trichosporonosis, triazoles were more effective than amphotericin B [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/56\">",
"     56",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/0/32773?source=see_link\">",
"     Flucytosine",
"    </a>",
"    has shown some synergistic activity against Trichosporon spp when combined with amphotericin B [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/19\">",
"     19",
"    </a>",
"    ]. &nbsp;In vitro resistance to flucytosine has been reported in some strains.",
"   </p>",
"   <p>",
"    The echinocandins are",
"    <strong>",
"     not",
"    </strong>",
"    active against Trichosporon spp. A case of invasive trichosporonosis was reported in a hematopoietic cell transplant recipient receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10486?source=see_link\">",
"     caspofungin",
"    </a>",
"    to prevent aspergillosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical experience in the treatment of trichosporonosis suggests that the drug used for treatment is probably not as important as the status of the underlying disease of the host. It is probable that no antifungal therapy will be effective with profound and prolonged neutropenia. In patients with disseminated infections due to Trichosporon spp or B. capitatus, we recommend initiating antifungal therapy with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    (6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 12 hours for two doses, then 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV twice daily) in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    (a lipid formulation at 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV daily or amphotericin B deoxycholate at 0.7 to 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV daily); we prefer a lipid formulation of amphotericin B over amphotericin B deoxycholate since the former is associated with less nephrotoxicity and fewer infusion-related adverse effects.",
"   </p>",
"   <p>",
"    Serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    trough concentrations should be checked to ensure adequate dosing, and once patients are stable on intravenous therapy they can be switched to oral voriconazole (200 mg twice daily) with continued monitoring of serum levels as indicated. Although debate remains over the optimal target concentration of voriconazole, available data suggest a therapeutic range of greater than 1",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    and less than 5.5",
"    <span class=\"nowrap\">",
"     mg/L.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=see_link&amp;anchor=H26#H26\">",
"     \"Pharmacology of azoles\", section on 'Serum drug concentration monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At the same time that antifungal therapy is initiated, attention needs to be paid to the possibility of reversing any immunosuppressive conditions. Using stimulatory cytokines to increase neutrophil counts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/58\">",
"     58",
"    </a>",
"    ] or reducing the doses of glucocorticoids or other immunosuppressant medications are important factors in the treatment of these infections. Surgery appears to be indicated for those patients with local wound involvement or endocarditis. There is no experience with surgery for lung or brain lesions. Removal of intravenous catheters should be done in patients who have fungemia.",
"   </p>",
"   <p>",
"    If the patient recovers, consideration should be given to maintaining chronic suppressive therapy since late relapses have occurred; oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    is the easiest agent to administer for this purpose. Chronic suppressive therapy is especially important for patients with endocarditis or CNS involvement. For patients with chronic immunosuppressive conditions, such as organ transplantation, therapy should probably be continued indefinitely.",
"   </p>",
"   <p>",
"    Some patients will recover from their infections and will appear stable off antifungal therapy. If they subsequently become immunocompromised, as with repeat chemotherapy or antirejection therapy, systemic antifungal therapy probably should be restarted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive infections with Trichosporon spp and B. capitatus carry very high mortality rates. The only cures of infection have been seen in those patients who were either not neutropenic at the time of diagnosis or who recovered from their neutropenia quickly once the infection was diagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasional patients with endocarditis due to Trichosporon spp or B. capitatus have survived for a period of time. One patient with T. beigelii prosthetic valve infection lived for four years after two valve replacements and prolonged antifungal therapy, but ultimately died of disseminated trichosporonosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/27\">",
"     27",
"    </a>",
"    ]. Another patient with B. capitatus prosthetic valve infection died two months after diagnosis despite two additional valve replacements and antifungal therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with localized disease, such as wound infections or cellulitis due to T. beigelii, have apparently been cured with surgical debridement and prolonged antifungal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/36,51\">",
"     36,51",
"    </a>",
"    ]. Some patients with positive blood cultures for T. beigelii have also been apparently cured of infection. Examples include a patient with Trichosporon fungemia thought to be due to injection drug use [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/59\">",
"     59",
"    </a>",
"    ] and a non-neutropenic patient with extensive burns who had fungemia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/23\">",
"     23",
"    </a>",
"    ]. In another report, a 14 year-old patient who had undergone an allogeneic bone marrow transplant for acute lymphoid leukemia was diagnosed with CNS involvement due to B. capitatus and survived for more than one year on antifungal therapy with resolution of her symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1785/abstract/50\">",
"     50",
"    </a>",
"    ]. When she subsequently died of interstitial pneumonia, residual fungal infection was found in the meninges at autopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455289564\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trichosporon species and Blastoschizomyces capitatus are related fungi and are rare causes of invasive infection in humans. Trichosporon spp can be found as a constituent of normal flora but can also cause both superficial and invasive infections in humans. Invasive disease due to Trichosporon spp occurs almost exclusively in immunocompromised hosts, appears to be increasing in frequency, and is usually fatal. This fungus also causes a characteristic infection of hair shafts called white piedra. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455289916\">",
"    <span class=\"h2\">",
"     Superficial infection",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      White piedra occurs primarily in immunocompetent patients in tropical climates but also occur in some temperate regions. Patients with white piedra are usually asymptomatic, and only seek medical attention because of the grossly visible nodules on the affected hair. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Superficial infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of white piedra is suggested by the characteristic nodules on the shafts of affected hairs. Examination of these nodules mounted on a slide with 10 percent potassium hydroxide shows septate hyphae with arthroconidia. Cultures of the nodules will grow Trichosporon spp in a few days. (See",
"      <a class=\"local\" href=\"#H455289667\">",
"       'Superficial infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of white piedra is best accomplished by shaving off all the hair in the affected areas and then applying a topical azole antifungal such as 2 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"       ketoconazole",
"      </a>",
"      shampoo for several months. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Superficial infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455289924\">",
"    <span class=\"h2\">",
"     Invasive infection",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive Trichosporon spp infections occur almost exclusively in immunocompromised patients. The most common species to cause invasive infection is T. asahii. The majority of trichosporonosis cases have been seen in patients with hematologic malignancies, often in the setting of neutropenia. B. capitatus has only been described as a systemic pathogen, and the affected patients have had some underlying immunocompromising condition, usually neutropenia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive infections due to Trichosporon species can be divided into disseminated and localized forms. The disseminated form is more common; the patient typically has an acute febrile illness that progresses rapidly to multiorgan failure. Disseminated infections due to B. capitatus present in a fashion similar to those due to Trichosporon spp. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In disseminated Trichosporon spp infections, cultures of blood, urine, sputum, cerebrospinal fluid, and tissue have all yielded the fungus. Blood cultures are frequently positive in disseminated infection. Culture and histopathology of skin lesions have also been helpful in establishing the diagnosis in disseminated infections. (See",
"      <a class=\"local\" href=\"#H455289674\">",
"       'Invasive infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of invasive infections due to either Trichosporon spp or B. capitatus is extremely difficult because of the profound immunosuppression and severe underlying diseases present in most infected patients. The optimal antifungal agent and duration of therapy are not known, but tentative recommendations can be made based on in vitro susceptibility data (",
"      <a class=\"graphic graphic_table graphicRef71985 \" href=\"UTD.htm?29/2/29742\">",
"       table 1",
"      </a>",
"      ) and clinical experience. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Invasive infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with disseminated infections due to Trichosporon spp or B. capitatus, we recommend initiating antifungal therapy with intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"       voriconazole",
"      </a>",
"      (6",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 12 hours for two doses, then 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV twice daily) in combination with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      (a lipid formulation at 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV daily or amphotericin B deoxycholate at 0.7 to 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV daily); we prefer a lipid formulation of amphotericin B over amphotericin B deoxycholate since the former is associated with less nephrotoxicity and fewer infusion-related adverse effects. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Invasive infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive infections with Trichosporon spp and B. capitatus carry very high mortality rates. The only cures of infection have been seen in those patients who were either not neutropenic at the time of diagnosis or who recovered from their neutropenia quickly once the infection was diagnosed. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/1\">",
"      Gu&eacute;ho E, Smith MT, de Hoog GS, et al. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek 1992; 61:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/2\">",
"      Gu&eacute;ho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses 1994; 37:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/3\">",
"      Chagas-Neto TC, Chaves GM, Colombo AL. Update on the genus Trichosporon. Mycopathologia 2008; 166:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/4\">",
"      Sugita T, Nishikawa A, Shinoda T, Kume H. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients. J Clin Microbiol 1995; 33:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/5\">",
"      Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 2009; 49:e11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/6\">",
"      Hickey PW, Sutton DA, Fothergill AW, et al. Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol 2009; 47:3091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/7\">",
"      Kreger-Van Rij JN, Veenhuis M. Septal pores in Trichosporon cutaneum. Sabouraudia 1971; 9:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/8\">",
"      Gu&eacute;ho E, Improvisi L, Christen R, de Hoog GS. Phylogenetic relationships of Cryptococcus neoformans and some related basidiomycetous yeasts determined from partial large subunit rRNA sequences. Antonie Van Leeuwenhoek 1993; 63:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/9\">",
"      McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 1985; 21:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/10\">",
"      Polacheck I, Salkin IF, Kitzes-Cohen R, Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol 1992; 30:2318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/11\">",
"      Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43:1818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/12\">",
"      von Arx JA. Notes on Dipodascus, Endomyces and Geotrichum with the description of two new species. Antonie Van Leeuwenhoek 1977; 43:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/13\">",
"      Rose HD, Kurup VP. Colonization of hospitalized patients with yeast-like organisms. Sabouraudia 1977; 15:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/14\">",
"      Haupt HM, Merz WG, Beschorner WE, et al. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 1983; 147:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/15\">",
"      Ellner K, McBride ME, Rosen T, Berman D. Prevalence of Trichosporon beigelii. Colonization of normal perigenital skin. J Med Vet Mycol 1991; 29:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/16\">",
"      Torssander J, Carlsson B, von Krogh G. Trichosporon beigelii: increased occurrence in homosexual men. Mykosen 1985; 28:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/17\">",
"      Kalter DC, Tschen JA, Cernoch PL, et al. Genital white piedra: epidemiology, microbiology, and therapy. J Am Acad Dermatol 1986; 14:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/18\">",
"      Yoshida K, Ando M, Sakata T, Araki S. Prevention of summer-type hypersensitivity pneumonitis: effect of elimination of Trichosporon cutaneum from the patients' homes. Arch Environ Health 1989; 44:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/19\">",
"      Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993; 5:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/20\">",
"      Kontoyiannis DP, Torres HA, Chagua M, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 2004; 36:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/21\">",
"      Barchiesi F, Morbiducci V, Ancarani F, et al. Trichosporon beigelii fungaemia in an AIDS patient. AIDS 1993; 7:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/22\">",
"      Leaf HL, Simberkoff MS. Invasive trichosporonosis in a patient with the acquired immunodeficiency syndrome. J Infect Dis 1989; 160:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/23\">",
"      Hajjeh RA, Blumberg HM. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis 1995; 20:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/24\">",
"      Finkelstein R, Singer P, Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med 1989; 86:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/25\">",
"      Sp&aacute;nik S, Koll&aacute;r T, Gyarf&aacute;s J, et al. Successful treatment of catheter-associated fungemia due to Candida krusei and Trichosporon beigelii in a leukemic patient receiving prophylactic itraconazole. Eur J Clin Microbiol Infect Dis 1995; 14:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/26\">",
"      Vasta S, Menozzi M, Scim&eacute; R, et al. Central catheter infection by Trichosporon beigelii after autologous blood stem cell transplantation. A case report and review of the literature. Haematologica 1993; 78:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/27\">",
"      Martinez-Lacasa J, Ma&ntilde;a J, Niub&oacute; R, et al. Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii. Eur J Clin Microbiol Infect Dis 1991; 10:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/28\">",
"      Keay S, Denning DW, Stevens DA. Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review. Rev Infect Dis 1991; 13:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/29\">",
"      Singh S, Singh N, Kochhar R, et al. Contamination of an endoscope due to Trichosporon beigelli. J Hosp Infect 1989; 14:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/30\">",
"      Schleupner CJ, Hamilton JR. A pseudoepidemic of pulmonary fungal infections related to fiberoptic bronchoscopy. Infect Control 1980; 1:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/31\">",
"      Gurgui M, Sanchez F, March F, et al. Nosocomial outbreak of Blastoschizomyces capitatus associated with contaminated milk in a haematological unit. J Hosp Infect 2011; 78:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/32\">",
"      Ellner KM, McBride ME, Kalter DC, et al. White piedra: evidence for a synergistic infection. Br J Dermatol 1990; 123:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/33\">",
"      Yuen KY, Seto WH, Li KS, Leung R. Trichosporon beigelii peritonitis in continuous ambulatory peritoneal dialysis. J Infect 1990; 20:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/34\">",
"      De Saedeleer B, Sennesael J, Van der Niepen P, Verbeelen D. Intraperitoneal fluconazole therapy for Trichosporon cutaneum peritonitis in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1994; 9:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/35\">",
"      Ahlm&eacute;n J, Edebo L, Eriksson C, et al. Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report. Perit Dial Int 1989; 9:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/36\">",
"      Greenberg RG, Berger TG. Postoperative Trichosporon beigelii soft tissue infection. J Dermatol Surg Oncol 1989; 15:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/37\">",
"      Mathews MS, Prabhakar S. Chronic meningitis caused by Trichosporon beigelii in India. Mycoses 1995; 38:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/38\">",
"      Sheikh HA, Mahgoub S, Badi K. Postoperative endophthalmitis due to Trichosporon cutaneum. Br J Ophthalmol 1974; 58:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/39\">",
"      Lyman CA, Garrett KF, Pizzo PA, Walsh TJ. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen. J Infect Dis 1994; 170:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/40\">",
"      Schaffner A, Davis CE, Schaffner T, et al. In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest 1986; 78:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/41\">",
"      Hospenthal D, Belay T, Lappin P, et al. Disseminated trichosporonosis in a neutropenic murine model. Mycopathologia 1993; 122:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/42\">",
"      Nahass GT, Rosenberg SP, Leonardi CL, Penneys NS. Disseminated infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations. Arch Dermatol 1993; 129:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/43\">",
"      Lyman CA, Devi SJ, Nathanson J, et al. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995; 33:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/44\">",
"      Tashiro T, Nagai H, Nagaoka H, et al. Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 1995; 108:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/45\">",
"      Hsiao GH, Chang CC, Chen JC, et al. Trichosporon beigelii fungemia with cutaneous dissemination. A case report and literature review. Acta Derm Venereol 1994; 74:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/46\">",
"      Pi&eacute;rard GE, Read D, Pi&eacute;rard-Franchimont C, et al. Cutaneous manifestations in systemic trichosporonosis. Clin Exp Dermatol 1992; 17:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/47\">",
"      Sidarous MG, O'Reilly MV, Cherubin CE. A case of Trichosporon beigelii endocarditis 8 years after aortic valve replacement. Clin Cardiol 1994; 17:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/48\">",
"      Surmont I, Vergauwen B, Marcelis L, et al. First report of chronic meningitis caused by Trichosporon beigelii. Eur J Clin Microbiol Infect Dis 1990; 9:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/49\">",
"      Celik AD, Ozaras R, Kantarcioglu S, et al. Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature. Rheumatol Int 2009; 29:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/50\">",
"      Girmenia C, Micozzi A, Venditti M, et al. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis 1991; 10:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/51\">",
"      Anaissie E, Gokaslan A, Hachem R, et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/52\">",
"      Venditti M, Posteraro B, Morace G, Martino P. In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemother 1991; 3:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/53\">",
"      Antachopoulos C, Papakonstantinou E, Dotis J, et al. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J Pediatr Hematol Oncol 2005; 27:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/54\">",
"      Ramos JM, Cuenca-Estrella M, Gutierrez F, et al. Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism. J Clin Microbiol 2004; 42:2341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/55\">",
"      Bouza E, Mu&ntilde;oz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect 2004; 10 Suppl 1:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/56\">",
"      Walsh TJ, Lee JW, Melcher GP, et al. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992; 166:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/57\">",
"      Goodman D, Pamer E, Jakubowski A, et al. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis 2002; 35:E35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/58\">",
"      Grauer ME, Bokemeyer C, Bautsch W, et al. Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor. Infection 1994; 22:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1785/abstract/59\">",
"      Moreno S, Buz&oacute;n L, S&aacute;nchez-Sousa A. Trichosporon capitatum fungemia and intravenous drug abuse. Rev Infect Dis 1987; 9:1202.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2456 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-41.196.66.12-0A8F4C59FF-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1785=[""].join("\n");
var outline_f1_47_1785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H455289564\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MYCOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Superficial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Invasive infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455289667\">",
"      Superficial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455289674\">",
"      Invasive infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Superficial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Invasive infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H455289564\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455289916\">",
"      Superficial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455289924\">",
"      Invasive infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2456\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2456|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/2/29742\" title=\"table 1\">",
"      MICs for other yeasts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10071?source=related_link\">",
"      Hepatosplenic candidiasis (chronic disseminated candidiasis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=related_link\">",
"      Pharmacology of azoles",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_47_1786="Clinical manifestations and evaluation of mushroom poisoning";
var content_f1_47_1786=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and evaluation of mushroom poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Timothy J Wiegand, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/47/1786/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/47/1786/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/47/1786/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H21617115\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushroom poisoning occurs frequently, but serious toxicity is uncommon. There are 12 groups of identified mushroom toxins with 14 described clinical syndromes (",
"    <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"     table 1",
"    </a>",
"    ). Defining which clinical syndrome predominates, initiating general supportive care, and administering any specific treatments for that syndrome are the key steps in the recognition and management of mushroom poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of mushroom poisoning syndromes and the diagnostic evaluation of patients with mushroom poisoning are reviewed here. The general management of mushroom poisoning, and the diagnosis and treatment of poisoning caused by potentially lethal amatoxin-containing mushrooms (eg, Amanita phalloides) or by Amanita smithiana are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H5135071#H5135071\">",
"     \"Management of mushroom poisoning\", section on 'General management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=see_link\">",
"     \"Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=see_link\">",
"     \"Amanita smithiana mushroom poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617122\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are over 10,000 species of mushrooms worldwide, but of these, only 50 to 100 are potentially toxic [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. In the United States, approximately 6000 mushroom exposures occur annually [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/2\">",
"     2",
"    </a>",
"    ]. Most of these patients experience no toxic effects or only mild or moderate symptoms. Over half of mushroom ingestions occur in children less than six years of age. In most cases, pediatric exposures are limited to a partial or single bite of nontoxic or minimally toxic mushrooms (",
"    <a class=\"graphic graphic_picture graphicRef76207 \" href=\"UTD.htm?8/16/8453\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef68114 \" href=\"UTD.htm?12/19/12592\">",
"     picture 2",
"    </a>",
"    ). Even in the uncommon cases of amatoxin-containing mushroom exposures (",
"    <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"     picture 4",
"    </a>",
"    ), children typically do well due to the limited amount of toxins available in the small amount of mushroom usually ingested. In the United States, no pediatric fatalities due to ingestion of a single mushroom have been reported in over 25 years of National Poison Data System surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When serious toxicity or mortality due to mushroom ingestion does occur, it typically results from consumption of misidentified mushrooms by foraging adults and others who shared the meal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,2,6\">",
"     1,2,6",
"    </a>",
"    ]. A common scenario involves amateur mushroom hunters or recent immigrants who mistake a toxic mushroom for an edible variety with similar morphologic features (eg, Gyromitra esculenta mistaken for Morchella esculenta (",
"    <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"     picture 5",
"    </a>",
"    ); Amanita species (",
"    <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"     picture 4",
"    </a>",
"    ) mistaken for Agaricus species) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In up to 95 percent of cases, the species of mushroom ingested is not identified [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/2\">",
"     2",
"    </a>",
"    ]. Thus, one must rely upon the presenting signs and symptoms to aid in the clinical diagnosis and to guide treatment recommendations. (See",
"    <a class=\"local\" href=\"#H21619983\">",
"     'Mushroom poisoning syndromes'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H21617129\">",
"     'Evaluation'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H5135071#H5135071\">",
"     \"Management of mushroom poisoning\", section on 'General management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21619983\">",
"    <span class=\"h1\">",
"     MUSHROOM POISONING SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are 12 groups of identified mushroom toxins found in multiple different mushroom species with 14 described clinical syndromes (",
"    <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21621437\">",
"    <span class=\"h2\">",
"     Acute symptom onset (&lt;6 hours after ingestion)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushrooms that only cause acute toxicity are rarely life-threatening (",
"    <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"     table 1",
"    </a>",
"    ). However, early symptoms do not exclude the possibility of consumption of potentially lethal mushrooms, especially if more than one type of mushroom was eaten.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21621536\">",
"    <span class=\"h3\">",
"     Acute gastroenteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of mushroom species cause acute gastroenteritis soon after ingestion without any further toxicity. Often these exposures occur when children take a bite of a &ldquo;little brown mushroom&rdquo; (",
"    <a class=\"graphic graphic_picture graphicRef76207 \" href=\"UTD.htm?8/16/8453\">",
"     picture 1",
"    </a>",
"    ) while playing outside in the backyard [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. This category of toxicity accounts for most mushroom poisoning reported to regional poison centers in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/2\">",
"     2",
"    </a>",
"    ]. Chlorophyllum molybdites is one of the more common &ldquo;backyard mushrooms&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With ingestion of these mushrooms, symptoms occur within one to three hours and include nausea, vomiting, and abdominal cramping as well as diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/4\">",
"     4",
"    </a>",
"    ]. Close attention to the history of ingestion and the timing associated with the onset of symptoms is important to differentiate acute gastroenteritis from the more concerning delayed gastroenteritis that may indicate consumption of a more lethal variety of mushroom toxins (eg, amatoxins, gyromitrin, orellanine). (See",
"    <a class=\"local\" href=\"#H21619990\">",
"     'Delayed gastroenteritis and liver toxicity'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H21619997\">",
"     'Delayed gastroenteritis, seizures, and liver toxicity'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H21620032\">",
"     'Delayed renal failure'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H21620046\">",
"     'Delayed rhabdomyolysis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An exception to this general rule applies to the Northwest United States, where patients who consume Amanita smithiana may develop acute gastroenteritis within two hours of ingestion, which is then followed by renal failure approximately 24 hours later. (See",
"    <a class=\"local\" href=\"#H507571\">",
"     'Delayed gastroenteritis and renal failure'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=see_link\">",
"     \"Amanita smithiana mushroom poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Care of gastroenteritis is supportive and includes rehydration and assessment for electrolyte abnormalities. Rarely, hypovolemic shock may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129419#H1129419\">",
"     \"Management of mushroom poisoning\", section on 'Vomiting and diarrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21621724\">",
"    <span class=\"h3\">",
"     Hallucinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallucinogenic effects produced by the ingestion of mushrooms containing psilocybin and psilocin (also known as &ldquo;magic mushrooms&rdquo;) have been known for thousands of years by indigenous communities in North and South America [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ]. Specific mushroom species that contain psilocybin and psilocin include Psilocybe, Conocybe, Gynmopilus, and Panaeolus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/4\">",
"     4",
"    </a>",
"    ]. These mushrooms grow throughout the United States and Europe, especially in warm, moist climates and are commonly abused for recreational purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psilocybin and psilocin are stable alkaloids which are chemically related to lysergic acid diethylamide (LSD) and serotonin but are present in small amounts in both dried and fresh mushrooms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/4\">",
"     4",
"    </a>",
"    ]. Hallucinatory effects require the ingestion of several caps of fresh mushrooms (eg, 3 to 60 caps) and up to 2 g of dried mushrooms.",
"   </p>",
"   <p>",
"    Feelings of euphoria and subsequent sensory distortion develop within 30 minutes to two hours after ingesting these mushrooms and are commonly associated with mild tachycardia and dilated pupils [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Frank hallucinations may also occur. The duration of symptoms is typically 4 to 12 hours after mushroom consumption. Treatment is supportive. Benzodiazepines may be necessary for anxiety or panic provoked by the psychoactive effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129426#H1129426\">",
"     \"Management of mushroom poisoning\", section on 'Agitation, delirium, and/or hallucinations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21621879\">",
"    <span class=\"h3\">",
"     CNS excitation and depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;This syndrome is caused by muscimol and ibotenic acid which are concentrated in the caps of the mushrooms, Amanita muscaria, Amanita pantherina, and other related mushroom species (",
"    <a class=\"graphic graphic_picture graphicRef61933 \" href=\"UTD.htm?13/28/13768\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. A. muscaria mushrooms are the prototypic large red or orange capped mushroom with white plaques or spots. These mushrooms are also known as fly agaric mushrooms because of their ability to attract and kill flies that land on them. A. muscaria and A. pantherina species have been used for thousands of years because of their psychoactive effects, and cases of poisoning still occur in individuals who ingest them for their hallucinatory effects. The toxins ibotenic acid and muscimol are water-soluble. Peeling the skin of the cap, parboiling the mushrooms, and discarding the water may detoxify the mushrooms prior to consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ibotenic acid and muscimol have very similar chemical structures, but opposite clinical effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ]. Muscimol is a central nervous system (CNS) depressant with structural similarities to gamma aminobutyric acid (GABA). In contrast, ibotenic acid has excitatory effects at glutamic acid receptors in the CNS. Mushrooms in this class (including A. muscaria) do not contain sufficient muscarine to cause cholinergic effects. (See",
"    <a class=\"local\" href=\"#H21622033\">",
"     'Cholinergic poisoning'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Clinical findings typically occur within 30 minutes to three hours of ingestion and include [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Somnolence, coma",
"     </li>",
"     <li>",
"      Hallucinations",
"     </li>",
"     <li>",
"      Dizziness",
"     </li>",
"     <li>",
"      Dysphoria",
"     </li>",
"     <li>",
"      Bizarre behavior",
"     </li>",
"     <li>",
"      Seizures (primarily in children) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Nausea, vomiting, diarrhea, and abdominal cramping",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of poisonings in this mushroom group is supportive and should include prompt management of delirium, agitation, or seizures and hydration in a monitored setting. Toxicity usually lasts between 4 and 24 hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129426#H1129426\">",
"     \"Management of mushroom poisoning\", section on 'Agitation, delirium, and/or hallucinations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129433#H1129433\">",
"     \"Management of mushroom poisoning\", section on 'Seizures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129419#H1129419\">",
"     \"Management of mushroom poisoning\", section on 'Vomiting and diarrhea'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21622033\">",
"    <span class=\"h3\">",
"     Cholinergic poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholinergic excess results from the ingestion of muscarine, a toxin present in many species of mushrooms throughout the world [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Among these, the species Inocybe and Clitocybe are frequently the source of poisoning. They commonly grow on lawns and in parks.",
"   </p>",
"   <p>",
"    Some species of Amanita, including Amanita muscaria (",
"    <a class=\"graphic graphic_picture graphicRef61933 \" href=\"UTD.htm?13/28/13768\">",
"     picture 6",
"    </a>",
"    ), do contain very small amounts of muscarine, but not enough to cause cholinergic symptoms. (See",
"    <a class=\"local\" href=\"#H21621879\">",
"     'CNS excitation and depression'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Muscarine is structurally similar to acetylcholine and causes toxicity by binding to postganglionic cholinergic neurons in the autonomic nervous system. Muscarine does not readily cross the blood-brain barrier.",
"   </p>",
"   <p>",
"    Clinical effects usually begin within 30 minutes after ingestion. Patients develop bradycardia, diaphoresis, salivation, lacrimation, bronchospasm, bronchorrhea, and incontinence. Unlike other cholinergic poisoning (eg, pesticide cholinesterase inhibitors) muscarine toxicity is not typically life-threatening and is usually short-lived unless large amounts of mushrooms were consumed [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/15\">",
"     15",
"    </a>",
"    ]. However, death due to refractory bradycardia and shock occurring 10 hours after mushroom consumption in an adult has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of muscarine poisoning consists of administration of anticholinergic agents (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/20/11591?source=see_link\">",
"     glycopyrrolate",
"    </a>",
"    ) and intravenous fluids to manage dehydration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129440#H1129440\">",
"     \"Management of mushroom poisoning\", section on 'Cholinergic excess'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21622148\">",
"    <span class=\"h3\">",
"     Disulfuram-like reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The toxin coprine, when ingested before consumption of ethanol, results in a disulfiram-like reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4,17\">",
"     1,4,17",
"    </a>",
"    ]. Coprinus atramentarius, the &ldquo;inky cap&rdquo; mushroom, and related species (",
"    <a class=\"graphic graphic_picture graphicRef79235 \" href=\"UTD.htm?26/16/26886\">",
"     picture 7",
"    </a>",
"    ) are most commonly associated with this syndrome. Coprine is heat-stable, so boiling or cooking the mushrooms does not prevent toxicity.",
"   </p>",
"   <p>",
"    The metabolites of coprine, including 1-aminocyclopropanol and cyclopropanone hydrate, irreversibly inhibit aldehyde dehydrogenase [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4,17\">",
"     1,4,17",
"    </a>",
"    ]. This effect causes a marked elevation of blood aldehyde when ethanol is ingested several hours to seven days after Coprinus mushroom consumption. However, if alcohol is ingested at the same time as coprine-containing mushrooms, toxicity often does not occur or is lessened because the metabolism of coprine is slower than the normal hepatic elimination of ethanol.",
"   </p>",
"   <p>",
"    Clinical effects usually occur within two hours of ethanol ingestion and include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Flushing of the face, neck, and trunk",
"     </li>",
"     <li>",
"      Nausea and vomiting",
"     </li>",
"     <li>",
"      Tachycardia",
"     </li>",
"     <li>",
"      Palpitations",
"     </li>",
"     <li>",
"      Chest pain",
"     </li>",
"     <li>",
"      Dyspnea",
"     </li>",
"     <li>",
"      Marked apprehensiveness",
"     </li>",
"     <li>",
"      Rarely, hypotension, cardiac dysrhythmia, confusion,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of toxicity is supportive. Clinical findings are self-limited and typically resolve after three to six hours, although, they can rarely persist as long as 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129419#H1129419\">",
"     \"Management of mushroom poisoning\", section on 'Vomiting and diarrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alcohol intolerance can also be precipitated by mushroom species other than Coprinus atramentarius (eg, Lepiota aspera). Although the pathophysiology of intolerance and toxicity is not well characterized, the treatment is the same [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/18\">",
"     18",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21621445\">",
"    <span class=\"h2\">",
"     Delayed symptom onset (&gt;6 hours after ingestion)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushrooms that cause symptoms more than six hours after consumption are associated with serious and potentially lethal toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H507571\">",
"    <span class=\"h3\">",
"     Delayed gastroenteritis and renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushrooms that contain allenic norleucine, including Amanita smithiana, found in the Pacific Northwest, and other Amanita species found in France, Spain, Portugal, Germany, Italy, and Japan may cause acute renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Amanita smithiana may be mistaken for the edible mushroom, Tricholoma magnivelare, also called the Matsutake mushroom, which is used extensively in Japanese cooking. Unlike Cortinarius species, these mushrooms also cause gastroenteritis, typically within 2 to 12 hours of ingestion. Evidence of renal toxicity is usually present at 12 to 24 hours after ingestion, suggesting that the renal injury occurs acutely after mushroom consumption. Most patients will recover full renal function with general supportive care. Hemodialysis is occasionally required as a temporary measure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129419#H1129419\">",
"     \"Management of mushroom poisoning\", section on 'Vomiting and diarrhea'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129461#H1129461\">",
"     \"Management of mushroom poisoning\", section on 'Renal failure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The toxicity, clinical presentation, and treatment of patients with toxicity caused by Amanita smithiana is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=see_link\">",
"     \"Amanita smithiana mushroom poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21619990\">",
"    <span class=\"h3\">",
"     Delayed gastroenteritis and liver toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed onset of vomiting and diarrhea approximately 6 to 12 hours after mushroom ingestion followed by progressive liver toxicity is characteristic of amatoxin-containing mushrooms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"     3",
"    </a>",
"    ]. These highly toxic mushrooms include species from three different genera, including: Amanita (",
"    <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"     picture 4",
"    </a>",
"    ), Galerina, and Lepiota which grow primarily in Europe and North America [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,2,4,22\">",
"     1,2,4,22",
"    </a>",
"    ]. The vast majority of fatalities after mushroom ingestion are associated with exposures to the Amanita species [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Toxicity typically consists of three distinct clinical phases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first phase typically starts more than six hours after mushroom consumption and includes gastrointestinal effects which include a cholera-like diarrhea, vomiting, abdominal pain and subsequent dehydration.",
"     </li>",
"     <li>",
"      The second phase begins 24 to 36 hours after ingestion and is a quiescent interval where the patient typically improves with regard to symptoms although there may be laboratory evidence of evolving hepatotoxicity.",
"     </li>",
"     <li>",
"      During the third phase of poisoning, more than two days after mushroom consumption, a progressive and irreversible liver failure occurs, characterized by coagulopathy, acidosis, encephalopathy proceeding to hepatic coma (seizures may occur), hemorrhage, renal failure, and, within four to seven days, death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Aggressive gastrointestinal decontamination, including interruption of enterohepatic circulation of the toxin, and supportive care are the mainstays of therapy. The treatment for amatoxin-containing mushroom exposures is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129419#H1129419\">",
"     \"Management of mushroom poisoning\", section on 'Vomiting and diarrhea'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129454#H1129454\">",
"     \"Management of mushroom poisoning\", section on 'Liver failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=see_link&amp;anchor=H26667361#H26667361\">",
"     \"Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21619997\">",
"    <span class=\"h3\">",
"     Delayed gastroenteritis, seizures, and liver toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most patients exposed to Gyromitra species gastrointestinal symptoms predominate and develop about six hours after ingestion (although onset of symptoms sometimes occurs earlier). With severe poisoning, neurologic symptoms, including vertigo, ataxia, tremors, weakness and seizures can develop in conjunction with hepatotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4,24-26\">",
"     1,4,24-26",
"    </a>",
"    ]. Gyromitrin is present in many mushrooms of the Gyromitra genus with Gyromitra esculenta (",
"    <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"     picture 5",
"    </a>",
"    ) being one of the most commonly ingested species. These mushrooms grow in North America, Europe, and Asia. Paxina species, Sarcosphaera coronaria, and Cyathipodia micropus also contain gyromitrin, but are less commonly encountered. Toxicity of the gyromitrin-containing mushrooms varies by geographic location. Toxicity from gyromitrin-containing mushrooms can be differentiated from toxicity due to hepatotoxic Amanita species based on seasonal considerations: Gyromitra mushrooms grow in the spring and early summer, whereas Amanita species grow in the fall. The appearance of the mushrooms can also be used to differentiate the two species. Gyromitras are described as having a &ldquo;brain-like&rdquo; appearance whereas the Amanitas are typically &ldquo;umbrella-shaped&rdquo; and have gills [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/26\">",
"     26",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Most commonly, Gyromitra esculenta (false morel) is mistaken for the similar appearing Morchella esculenta (morel). Although certain methods of preparation may limit the toxicity of gyromitrin-containing mushrooms (eg, parboiling), it is still recommended that all members of this family be avoided. &nbsp;",
"   </p>",
"   <p>",
"    Gyromitrin is hydrolyzed by liver alcohol dehydrogenase into acetaldehyde and monomethyl hydrazine, a substance similar to the hydrazines in rocket fuel [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/25\">",
"     25",
"    </a>",
"    ]. The mechanism of toxicity is inhibition of pyridoxal phosphate-related enzymatic reactions, which causes functional pyridoxine deficiency and ultimately leads to a depletion of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). Thus, delayed seizures intractable to anticonvulsant therapy may result.",
"   </p>",
"   <p>",
"    Clinical manifestations of gyromitrin toxicity include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delayed gastroenteritis (nausea, vomiting, abdominal pain, diarrhea) typically beginning 6 to 10 hours after ingestion",
"     </li>",
"     <li>",
"      Headaches, weakness, and muscle cramping",
"     </li>",
"     <li>",
"      Delayed seizures",
"     </li>",
"     <li>",
"      Delayed hepatoxicity, including liver failure",
"     </li>",
"     <li>",
"      Hemolysis (uncommon)",
"     </li>",
"     <li>",
"      Methemoglobinemia (uncommon)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most patients return to baseline health within a couple of days. However, mortality up to 10 percent has been reported in Eastern Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/4\">",
"     4",
"    </a>",
"    ]. Prompt treatment of seizures, hemolysis, and methemoglobinemia along with supportive care of gastroenteritis and hepatotoxicity are key aspects of treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129433#H1129433\">",
"     \"Management of mushroom poisoning\", section on 'Seizures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43753?source=see_link&amp;anchor=H16#H16\">",
"     \"Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\", section on 'Acute use of methylene blue'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620032\">",
"    <span class=\"h3\">",
"     Delayed renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The toxins orellanine, orellinine, cortinarin A, and cortinarin B, have been associated with acute renal failure occurring 3 to 20 days after ingestion of mushrooms, such as Cortinarius orellanus, Mycena pura, and Omphalatus orarius [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4,27\">",
"     1,4,27",
"    </a>",
"    ]. This syndrome has been described in the Pacific Northwest United States, Europe, and Japan.",
"   </p>",
"   <p>",
"    The toxin orellanine has chemical similarities with the herbicides, paraquat and diquat, and is concentrated in the kidney where it produces interstitial nephritis and tubulointerstitial fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/28\">",
"     28",
"    </a>",
"    ]. The cortinarins appear to have similar toxic effects but may require conversion by cytochrome oxidases in the liver to toxic metabolites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ]. Although orellanine is typically not detectable in blood or urine by the time patients come to medical attention, it can be detected in renal tissue obtained by biopsy up to six months after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initial symptoms due to Cortinarius ingestion are nonspecific and commonly consist of a headache, general malaise, nausea, vomiting, diarrhea, abdominal pain, myalgias, and dizziness that occur within four days of mushroom consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/30\">",
"     30",
"    </a>",
"    ]. Subsequently, renal toxicity is heralded by lumbar and back pain, oliguria, or polyuria with active urinary findings of pyuria, hematuria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    proteinuria. &nbsp;",
"   </p>",
"   <p>",
"    Treatment should consist of general supportive care for acute kidney injury with close monitoring of the serum creatinine [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. The impairment in renal function is frequently severe. In a systematic review of Cortinarius species mushroom poisoning in 90 patients, 62 patients developed evidence of renal toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/30\">",
"     30",
"    </a>",
"    ]. Forty-six patients required hemodialysis, 10 developed end stage renal failure, and 12 received kidney transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129461#H1129461\">",
"     \"Management of mushroom poisoning\", section on 'Renal failure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620046\">",
"    <span class=\"h3\">",
"     Delayed rhabdomyolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mushroom Tricholoma equestre, also known as &ldquo;man on horseback&rdquo;, has been reported to cause rhabdomyolysis when ingested in large amounts or in repeat meals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. T. equestre can be found throughout Europe or in North America in the late summer or early fall. The onset of symptoms from T. equestre poisoning typically occurs within 24 to 72 hours after mushroom consumption and include general fatigue with nausea, myalgias, and progressive weakness. Laboratory abnormalities include an elevated serum potassium and creatine kinase. Although the myotoxin contained in T. equestre remains unknown, extracts from this mushroom have produced muscle toxicity in an animal model. Treatment is supportive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=see_link&amp;anchor=H1129447#H1129447\">",
"     \"Management of mushroom poisoning\", section on 'Rhabdomyolysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620060\">",
"    <span class=\"h2\">",
"     Rare manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the above relatively common syndromes, several other disorders have been rarely described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620067\">",
"    <span class=\"h3\">",
"     Erythromelalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushrooms that contain acromelic acid (eg, Clitocybe acromelalga) have been associated with the following clinical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,34\">",
"     1,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sensory abnormalities, including distal paresthesias, allodynia (severe tactile pain), and burning pain in the extremities",
"     </li>",
"     <li>",
"      Erythema of the affected limbs",
"     </li>",
"     <li>",
"      Limb edema",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings typically have occurred more than 24 hours after mushroom consumption and may take months to resolve. Treatment consists of supportive care (eg, elevation of the extremities to reduce edema) and pain control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620074\">",
"    <span class=\"h3\">",
"     Delayed encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two rare scenarios have been associated with delayed encephalopathy after mushroom consumption [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with chronic renal failure, especially those receiving hemodialysis, who ingest Pleurocybella porrigens may develop delayed severe encephalopathy with altered mental status, seizures and respiratory failure from one to several days after consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/35\">",
"       35",
"      </a>",
"      ]. This mushroom is found in North America, northern Europe, and Japan, where it is sometimes added to miso soup. Boiling the mushroom appears to extract the toxin.",
"     </li>",
"     <li>",
"      A single case series describes delayed encephalopathy with ataxia after consumption of the mushroom Hapalopilus rutilans [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/36\">",
"       36",
"      </a>",
"      ].The patients presented with decreased visual acuity, lethargy, and weakness and were also noted to have elevated aminotransferase levels and creatinine concentrations in association with purple colored urine. Polyporic acid was identified as the likely toxin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620081\">",
"    <span class=\"h3\">",
"     Immune-mediated hemolytic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consumption of Paxillus involutus has been associated with an auto-immune hemolytic anemia hemoglobinuria, and acute kidney injury [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,37,38\">",
"     1,37,38",
"    </a>",
"    ]. Specific IgG antibodies were identified in one affected patient [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21620088\">",
"    <span class=\"h3\">",
"     Allergic bronchioalveolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalation of spores from the puffball mushrooms within the Lycoperdon species has produced a diffuse pneumonitis called lycoperdonosis with occasional progression to reticulonodular infiltrates and respiratory failure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1,40\">",
"     1,40",
"    </a>",
"    ]. The type of exposure that produces lycoperdonosis is typically intense including placement of the mushroom in the nose to stop epistaxis, intentional insufflation, and aerosolizing large amounts of the spores by stomping on the mushrooms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Treatment consists of the administration of corticosteroids and systemic antifungal agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617129\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs and symptoms may point to a specific type of mushroom poisoning (",
"    <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"     table 1",
"    </a>",
"    ). A regional poison control center should be contacted to discuss likely mushroom species ingested based upon clinical findings, identification of any mushrooms available for analysis, and treatment of specific toxic effects. Most poison control centers maintain active call lists of mycologists who are knowledgeable concerning local prevalence of mushroom genera and species and can assist in mushroom identification. To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617136\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key elements of the patient&rsquo;s history may help determine which species of mushroom was ingested as well as guide therapy. Important questions include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Were the mushrooms collected in a field, a pasture, or along or underneath trees? &ndash; Many of the major toxic mushrooms (eg, Amanita phalloides (",
"      <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"       picture 3",
"      </a>",
"      ), Amanita bisporigera (",
"      <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"       picture 4",
"      </a>",
"      ), Gyromitra esculenta (",
"      <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"       picture 5",
"      </a>",
"      ), Cortinarius species) tend to grow in woodlands and are often found in deciduous forests [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/42\">",
"       42",
"      </a>",
"      ]. Growing season as well as geographic variation may help an expert identify particular mushrooms [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/24,26\">",
"       24,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      What type of tree, if any, was the mushroom on or near, and was the tree living or dead? Many mushrooms with a variety of toxicities grow on dead stumps. Amanita species, in particular Amanita phalloides, may grow under or near oak or pine trees. &nbsp;",
"     </li>",
"     <li>",
"      Was more than one type of mushroom collected?",
"     </li>",
"     <li>",
"      How long after ingestion did symptoms develop? &ndash; Symptoms that develop more than six hours after ingestion indicate poisoning with potentially lethal mushroom toxins (eg, amatoxin (",
"      <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"       picture 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"       picture 4",
"      </a>",
"      ), gyromitrin (",
"      <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"       picture 5",
"      </a>",
"      ), or orellanine). Three caveats must be understood in relation to the six-hour timeframe, however: rarely, the amatoxin-containing mushrooms will cause symptoms before six hours; mushroom foragers often collect more than one type of mushroom and symptom onset before six hours does not rule out poisoning by a more dangerous mushroom; and in the United States Pacific Northwest, Amanita Smithiana poisoning may produce gastroenteritis symptoms before six hours.",
"     </li>",
"     <li>",
"      How much was eaten? &ndash; Information about the amount of mushrooms ingested may be useful in predicting the course and degree of poisoning once the patient becomes symptomatic.",
"     </li>",
"     <li>",
"      Were the mushrooms ingested for recreational hallucinatory effects (eg, mushrooms containing psilocybin or muscimol and ibotenic acid)?",
"     </li>",
"     <li>",
"      Were the mushrooms eaten at more than one meal? &ndash; Symptoms that are evident may be the result of the earlier ingestion rather than the most recent ingestion which increases the likelihood of life-threatening poisoning.",
"     </li>",
"     <li>",
"      What did the mushroom look like? &ndash; If no sample is available for identification, then a description may suggest the potential for serious, life-threatening toxicity. For example, mature amatoxin-containing mushrooms tend to be large and white (eg, Amanita bisporigera (",
"      <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"       picture 4",
"      </a>",
"      ), virosa or verna) or greenish-white (eg, Amanita phalloides (",
"      <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"       picture 3",
"      </a>",
"      )) with a large bulb on the end of the stalk or ring around the middle of the stalk. Gyromitrin-containing mushrooms have a brain-like appearance and are often confused with morels (Morchella esculenta) (",
"      <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"       picture 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Was any ethanol ingested with the mushroom? &ndash; Certain mushroom species (eg, Coprinus) can cause a disulfiram-like reaction when ethanol is ingested with or up to 48 hours after Coprinus mushroom consumption.",
"     </li>",
"     <li>",
"      Is everyone who ate the mushrooms ill? Is anyone who did not eat the mushrooms ill? &ndash; These questions help differentiate mushroom poisoning from other types of food poisoning. However, due to variations in amount ingested and possible types of mushrooms ingested (if more than one mushroom was present at the meal), not all persons who ingest toxic mushrooms may become poisoned.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other individuals who ate mushrooms along with the patient should be contacted. Symptomatic patients and any asymptomatic person who might be at risk for life-threatening toxicity (eg, amatoxin-, gyromitrin-, orellanine-containing mushrooms) warrant emergent medical evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617143\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification of poisoning based upon clinical presentation (eg, gastroenteritis, liver failure, seizures, cholinergic poisoning, hallucinations, renal failure (",
"    <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"     table 1",
"    </a>",
"    )) is most helpful in guiding further treatment and more quickly arrives at the type of mushroom ingested in most instances. (See",
"    <a class=\"local\" href=\"#H21619983\">",
"     'Mushroom poisoning syndromes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Consultation with a medical toxicologist is advised when evaluating patients with suspected mushroom poisoning since signs and symptoms of mushroom poisoning (eg, vomiting and diarrhea) may occur in more than one mushroom poisoning syndrome as well as with other toxic exposures (eg, food poisoning, botulism). To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    ). A list of medical toxicologists is also available online through the American College of Medical Toxicology website at",
"    <a class=\"external\" href=\"file://www.acmt.net/cgi/page.cgi?_id=18\">",
"     www.acmt.net/cgi/page.cgi?_id=18",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617150\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific testing to identify mushrooms and their toxins is discussed separately. (See",
"    <a class=\"local\" href=\"#H21617164\">",
"     'Mushroom identification'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Acute testing in patients with mushroom exposures is guided by the clinical presentation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic individuals with ingestions that are unlikely to be toxic may be observed without any testing.",
"     </li>",
"     <li>",
"      Asymptomatic patients with ingestion of potentially lethal mushrooms should undergo baseline assessment of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Serum electrolytes, calcium, and phosphate",
"     </li>",
"     <li>",
"      Blood urea nitrogen and serum creatinine",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      Serum creatine kinase",
"     </li>",
"     <li>",
"      Liver studies (eg, aspartate aminotransferase [AST], alanine aminotransferase [ALT], total protein, albumin, total and direct bilirubin)",
"     </li>",
"     <li>",
"      Prothrombin time (PT), partial thromboplastin time (PTT)",
"     </li>",
"     <li>",
"      Complete blood count with platelets",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic patients should undergo testing as described for asymptomatic patients with potentially lethal mushroom ingestion. In addition, they may warrant other studies based upon their clinical findings as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fulminant hepatic failure &ndash; serum glucose, blood gas determination, serum lactate, blood ammonia, and serum lactate dehydrogenase (LDH)",
"     </li>",
"     <li>",
"      Altered mental status &ndash; rapid blood glucose, blood gas determination, and, if hepatic encephalopathy is suspected or the patient shows signs of increased intracranial pressure, neuroimaging (eg, computed tomography of the brain) to assess for cerebral edema. &nbsp;",
"     </li>",
"     <li>",
"      Cyanosis not responsive to oxygen therapy or ingestion of mushrooms containing gyromitrin toxin &ndash; methemoglobin level",
"     </li>",
"     <li>",
"      Hypoxia or respiratory distress &ndash; blood gas determination, pulse oximetry, chest radiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617157\">",
"    <span class=\"h3\">",
"     Interpretation of results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrolyte abnormalities are often associated with gastrointestinal symptoms (eg, vomiting, abdominal pain, and diarrhea), are nonspecific and occur commonly in patients with mushroom poisoning.",
"   </p>",
"   <p>",
"    Liver studies are typically normal in most acute mushroom exposures, but following ingestion of mushrooms containing amatoxin or gyromitrin toxins (eg, Amanita virosa, Amanita phalloides, Gyromitra esculenta), liver enzymes will begin to rise on reassessment approximately 24 to 36 hours after ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"     3",
"    </a>",
"    ]. Thrombocytopenia, coagulopathy, hyperbilirubinemia, or hyperammonemia with encephalopathy indicates progressive toxicity in such patients and may be associated with gastrointestinal bleeding. Acidosis, hypoglycemia, and renal failure signifying hepatorenal syndrome are markers for poor prognosis.",
"   </p>",
"   <p>",
"    Acutely, renal insufficiency may occur as a nonspecific result of hypovolemic shock due to vomiting and diarrhea or may indicate ingestion of norleucine toxin (Amanita smithiana) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/19\">",
"     19",
"    </a>",
"    ]. Renal insufficiency occurring days to weeks after mushroom ingestion is characteristic of orellanine toxicity (Cortinarius mushroom species) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ingestion of gyromitrin-containing mushrooms (eg, Gyromitra esculenta) may cause methemoglobinemia. Hemolysis indicated by anemia, red blood cell fragments on blood smear, and hemoglobinuria may also occur or may indicate immune-mediated hemolytic anemia caused by Paxillus involutus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/25,38\">",
"     25,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elevated creatine kinase occurring one to three days after mushroom ingestion suggests rhabdomyolysis induced by mushrooms, such as Tricholoma equestre or Russula species (eg, Russula emetica) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inhalational &ldquo;puffball&rdquo; exposure (eg, Lycoperdon species) may cause respiratory symptoms in association with bilateral reticulonodular infiltrates (allergic bronchoalveolitis) seen on chest radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21617164\">",
"    <span class=\"h2\">",
"     Mushroom identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mushroom identification is usually not readily available during the acute phase of care, and most mushrooms causing toxicity are never correctly identified [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/2\">",
"     2",
"    </a>",
"    ]. However, if possible, determination of the specific type of mushroom ingested can be helpful for treatment recommendations and prognosis. Consultation with a medical toxicologist and professional mycologist is advised when attempting mushroom identification (US regional poison control center: 1-800-222-1222 or access the World Health Organization's list of international poison centers [",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    Whenever possible, samples of all ingested mushrooms should be obtained for potential identification by a professional mycologist [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/1\">",
"     1",
"    </a>",
"    ]. Whole mushrooms are preferred, but identification can be made on parts of the mushroom, especially the cap. Storage is facilitated by wrapping the mushrooms in wax paper, placing it in a paper bag, and refrigerating the sample [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"     3",
"    </a>",
"    ]. Storage in plastic bags should be avoided. Digital photographs of whole mushrooms can be immediately sent to a mycologist for inspection. Although they are insufficient to make a definitive diagnosis, photographs have been used successfully to exclude ingestion of a seriously toxic mushroom in time to assist with treatment decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, patients often ingest multiple mushrooms and have cooked, or otherwise damaged the fungi they have ingested, making direct identification difficult or impossible. In these situations, a centrifuged gastric aspirate may be obtained for microscopic evaluation of spores by a professional mycologist [",
"    <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Testing methods vary depending upon the mushroom sample available and include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Spore print analysis",
"      </strong>",
"      &ndash; Spore prints can successfully identify mushrooms with high specificity (",
"      <a class=\"graphic graphic_picture graphicRef55358 \" href=\"UTD.htm?34/14/35041\">",
"       picture 8",
"      </a>",
"      ). However, this procedure is typically not useful for patient management in the acute phase of mushroom poisoning because it requires fresh, intact, and carefully preserved mushroom caps, several hours to obtain the print, and a professional mycologist to perform the spore print correctly and interpret the results.",
"     </li>",
"     <li>",
"      <strong>",
"       Specific laboratory testing",
"      </strong>",
"      &ndash; Laboratory analysis in patients with mushroom exposure should be based upon their clinical presentation. Analysis for specific mycotoxins is difficult and not usually feasible in a time-frame that is of clinical utility. Assays for some of the most toxic mycotoxins are available and may be important to confirm the clinical impression in a critically ill patient. The clinician should contact a poison control center (US regional poison control center: 1-800-222-1222 or access the World Health Organization's list of international poison centers [",
"      <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"       www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"      </a>",
"      ]) to discuss appropriate testing methods, type of specimen needed, specimen handling, laboratories where testing is available, and interpretation of results. Specific assays for mycotoxins include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Enzyme-linked immunoassay (ELISA)",
"      </strong>",
"      &ndash; Urine and blood tests for amatoxins are not widely available, but sensitive tests do exist [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"       3",
"      </a>",
"      ]. Amatoxin is rapidly cleared from the blood; urine is the matrix of choice for testing for amatoxins. ELISA assays should be interpreted in conjunction with the clinical assessment. False positives have been reported with ingestion of mushroom species that do not contain amatoxins. ELISA may be of particular use in ruling out potential exposures to amatoxin-containing mushrooms in patients who present after mixed-mushroom exposures and have early onset of gastrointestinal symptoms. ELISA assays are most useful if samples are tested early in patient presentation. The sensitivity of ELISA assays decreases substantially after 36 hours [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Radioimmunoassay (RIA)",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      RIA&rsquo;s performed on urine detected amatoxin in 100 percent of cases for assays performed within 24 hours and in 80 percent of cases within 48 hours of known cyclopeptide-containing mushroom exposures. ELISA has largely replaced RIA methodology for identifying amatoxins [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Gas Chromatography-mass spectroscopy",
"       <span class=\"nowrap\">",
"        (GC/MS)",
"       </span>",
"      </strong>",
"      &ndash;",
"      <span class=\"nowrap\">",
"       GC/MS",
"      </span>",
"      has been used to confirm exposures to cyclopeptide-containing mushrooms, and it has been used to identify hydrazines found in gyromitrin-containing mushrooms.",
"      <span class=\"nowrap\">",
"       GC/MS",
"      </span>",
"      may aid in diagnosis of exposure to other mushrooms containing toxins, such as psilocybin or psilocin and orellanine [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/46\">",
"       46",
"      </a>",
"      ].",
"      <span class=\"nowrap\">",
"       GC/MS",
"      </span>",
"      has also been used to identify psilocin in",
"      <span class=\"nowrap\">",
"       chocolate/mushroom",
"      </span>",
"      concoctions by the Drug Enforcement Agency [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       High-Performance Liquid Chromatography (HPLC) and tandem mass spectroscopy",
"      </strong>",
"      &ndash; HPLC has been used to identify a variety of mycotoxins (eg, amatoxin, amelic acid) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"       3",
"      </a>",
"      ]. Typically only research or reference laboratories will be able to perform these assays.",
"     </li>",
"     <li>",
"      <strong>",
"       Polymerase chain reaction (PCR)",
"      </strong>",
"      &ndash; PCR tests have been developed for a variety of highly toxic mushrooms, including Amanita phalloides, Lepiota cristata, Lepiota brunneoincarnata, Inocybe asterospora, and toxic Japanese mushrooms (eg, Omphalotus japonicus, Clitocybe acromelalga, Tricholoma ustale, Entoloma rhodopolius) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/23,48\">",
"       23,48",
"      </a>",
"      ]. These tests are highly sensitive and specific and can even detect the presence of these mushrooms in difficult to use sources, such as cooked mushrooms, mushrooms mixed with pasta, and gastric aspirates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Meixner test",
"      </strong>",
"      &ndash; We do not recommend use of the Meixner test for determining the presence of amatoxin in mushroom samples [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/22,49\">",
"       22,49",
"      </a>",
"      ]. Although this test was used in the past as a means to identify amatoxin-containing mushrooms, it has been demonstrated to be unreliable with false positives as well as false negatives [",
"      <a class=\"abstract\" href=\"UTD.htm?1/47/1786/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. This test should also not be used by foragers to determine whether or not a mushroom is edible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21623937\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food poisoning caused by bacterial toxins (eg, Staphylococcus aureus enterotoxin, Bacillus cereus emetic toxin, foodborne botulism, shiga toxin producing E. coli [hemolytic uremic syndrome]) may also cause delayed onset of nausea, vomiting, abdominal pain, and diarrhea after eating contaminated food. In most situations, the ill patient will provide a food history that implicates the typical source of food poisoning (eg, undercooked meat, eggs, rice, salads, home-canned vegetables), and mushrooms are found not to have been consumed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=see_link&amp;anchor=H3#H3\">",
"     \"Differential diagnosis of microbial foodborne disease\", section on 'Approach to the patient'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, sometimes mushrooms are coingested with the food or are the source of the contamination (eg, botulism from canned mushrooms). When differentiating mushroom poisoning from food poisoning in these situations, the clinician should monitor for specific findings that point to the underlying etiology (eg, descending paralysis [botulism], hemolytic uremic syndrome [enterohemorrhagic E. coli], liver toxicity [amatoxin mushroom poisoning]) and provide comprehensive supportive care. When botulism is suspected, administration of antitoxin may also be indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link&amp;anchor=H12#H12\">",
"     \"Botulism\", section on 'Foodborne botulism'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link&amp;anchor=H21#H21\">",
"     \"Botulism\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14232?source=see_link\">",
"     \"Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When evaluating patients with renal insufficiency, liver failure, or rhabdomyolysis of unknown etiology, the clinician should remember to inquire about mushroom consumption because other persons who shared in the meal may also be at risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21619229\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct consultation with knowledgeable poison specialists, medical toxicologists, and mycologists is available through regional poison control centers. In the United States, call 1-800-222-1222 or access the World Health Organization's list of international poison centers (",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    ). We do",
"    <strong>",
"     not",
"    </strong>",
"    endorse the use of the internet for identification of toxic mushroom species without expert consultation.",
"   </p>",
"   <p>",
"    The toxicology section of the North American Mycological Association website provides lists of emergency identification volunteers available in North America, an overview of mushroom poisoning syndromes with pictures, and archived toxicology reports that describe specifics of poisoning cases in which NAMA mycologists provided assistance (",
"    <a class=\"external\" href=\"file://www.namyco.org/toxicology/index.html\">",
"     file://www.namyco.org/toxicology/index.html",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21619236\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mushroom ingestion occurs frequently but serious toxicity is uncommon. In most cases, the specific species of mushroom consumed is unknown. (See",
"      <a class=\"local\" href=\"#H21617122\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When serious mushroom poisoning does occur, it typically results from misidentification by amateur foragers. (See",
"      <a class=\"local\" href=\"#H21617122\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Classification of poisoning based upon clinical presentation (",
"      <a class=\"graphic graphic_table graphicRef77875 \" href=\"UTD.htm?11/28/11727\">",
"       table 1",
"      </a>",
"      ) is most helpful in achieving a working diagnosis and guiding further treatment. (See",
"      <a class=\"local\" href=\"#H21619983\">",
"       'Mushroom poisoning syndromes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21617129\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who ingest potentially lethal mushrooms (eg, Amanita bisporigera (",
"      <a class=\"graphic graphic_picture graphicRef52731 \" href=\"UTD.htm?17/35/17974\">",
"       picture 4",
"      </a>",
"      ), Amanita phalloides (",
"      <a class=\"graphic graphic_picture graphicRef73705 \" href=\"UTD.htm?6/63/7152\">",
"       picture 3",
"      </a>",
"      ), Gyromitra esculenta (",
"      <a class=\"graphic graphic_picture graphicRef64502 \" href=\"UTD.htm?31/32/32265\">",
"       picture 5",
"      </a>",
"      ), Cortinarius orellanus) typically develop signs of toxicity more than six hours after ingestion. However, clinical manifestations of poisoning that occur less than six hours after mushroom consumption do not exclude the potential for life-threatening toxicity, especially when more than one type of mushroom has been eaten. (See",
"      <a class=\"local\" href=\"#H21621437\">",
"       'Acute symptom onset (&lt;6 hours after ingestion)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21621445\">",
"       'Delayed symptom onset (&gt;6 hours after ingestion)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21617129\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ancillary testing in patients with mushroom exposures is guided by the clinical presentation. (See",
"      <a class=\"local\" href=\"#H21617150\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Whenever possible, samples of all ingested mushrooms should be obtained for potential identification by a trained mycologist. Whole mushrooms are preferred, but identification can be made on parts of the mushroom, especially the cap. Further storage is facilitated by wrapping the mushrooms in wax paper, placing it in a paper bag, and refrigerating the sample. Storage in plastic bags should be avoided. (See",
"      <a class=\"local\" href=\"#H21617164\">",
"       'Mushroom identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A regional poison control center should be contacted to help determine likely mushroom species ingested based upon clinical findings, identification of any mushrooms available for analysis, and treatment of specific toxic effects. In the United States, call 1-800-222-1222 or access the World Health Organization's list of international poison centers (",
"      <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"       www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21619229\">",
"       'Additional resources'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Goldfrank, LR. Mushrooms. In: Goldfrank's Toxicologic Emergencies, 9th, Nelson, LS, Lewin, NA, Howland, MA, et al. (Eds), McGraw-Hill, New York 2011. p.1522.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/2\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009; 47:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/3\">",
"      Berger KJ, Guss DA. Mycotoxins revisited: Part I. J Emerg Med 2005; 28:53.",
"     </a>",
"    </li>",
"    <li>",
"     Brent, J, Palmer, RB. Mushrooms. In: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, 4th edition, Shannon, MW, Borron, SW, Burns, MJ (Eds), Saunders Elsevier, Philadelphia, PA 2007. p.455.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/5\">",
"      Beuhler MC, Sasser HC, Watson WA. The Outcome of North American Pediatric Unintentional Mushroom Ingestions with Various Decontamination Treatments: An Analysis of 14 Years of TESS Data. Toxicon 2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/6\">",
"      Yamada EG, Mohle-Boetani J, Olson KR, Werner SB. Mushroom poisoning due to amatoxin. Northern California, Winter 1996-1997. West J Med 1998; 169:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/7\">",
"      Cole FM. Amanita phalloides in Victoria. Med J Aust 1993; 158:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/8\">",
"      Lehmann PF, Khazan U. Mushroom poisoning by Chlorophyllum molybdites in the Midwest United States. Cases and a review of the syndrome. Mycopathologia 1992; 118:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/9\">",
"      Stenklyft PH, Augenstein WL. Chlorophyllum molybdites--severe mushroom poisoning in a child. J Toxicol Clin Toxicol 1990; 28:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/10\">",
"      Passie T, Seifert J, Schneider U, Emrich HM. The pharmacology of psilocybin. Addict Biol 2002; 7:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/11\">",
"      Michelot D, Melendez-Howell LM. Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycol Res 2003; 107:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/12\">",
"      Tupalska-Wilczy��ska K, Ignatowicz R, Poziemski A, et al. [Amanita pantherina and Amanita muscaria poisonings--pathogenesis, symptoms and treatment]. Pol Merkur Lekarski 1997; 3:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/13\">",
"      Satora L, Pach D, Butryn B, et al. Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon 2005; 45:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/14\">",
"      Benjamin DR. Mushroom poisoning in infants and children: the Amanita pantherina/muscaria group. J Toxicol Clin Toxicol 1992; 30:13.",
"     </a>",
"    </li>",
"    <li>",
"     Handbook of Mushroom Poisoning: Diagnosis and Treatment, Rumack, BH, Spoerke, DG (Eds), CRC Press, Boca Raton 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/16\">",
"      Pauli JL, Foot CL. Fatal muscarinic syndrome after eating wild mushrooms. Med J Aust 2005; 182:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/17\">",
"      Michelot D. Poisoning by Coprinus atramentarius. Nat Toxins 1992; 1:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/18\">",
"      Haberl B, Pfab R, Berndt S, et al. Case series: Alcohol intolerance with Coprine-like syndrome after consumption of the mushroom Lepiota aspera (Pers.:Fr.) Qu&eacute;l., 1886 (Freckled Dapperling). Clin Toxicol (Phila) 2011; 49:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/19\">",
"      West PL, Lindgren J, Horowitz BZ. Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review. J Med Toxicol 2009; 5:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/20\">",
"      Saviuc P, Danel V. New syndromes in mushroom poisoning. Toxicol Rev 2006; 25:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/21\">",
"      Kirchmair M, Carrilho P, Pfab R, et al. Amanita poisonings resulting in acute, reversible renal failure: new cases, new toxic Amanita mushrooms. Nephrol Dial Transplant 2012; 27:1380.",
"     </a>",
"    </li>",
"    <li>",
"     Marquardt, K. Mushrooms; Mushrooms, Amatoxin-Type. In: Poisoning and Drug Overdose, 5th, Olson, K (Eds), McGraw-Hill, New York 2007. p.276.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/23\">",
"      Maeta K, Ochi T, Tokimoto K, et al. Rapid species identification of cooked poisonous mushrooms by using real-time PCR. Appl Environ Microbiol 2008; 74:3306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/24\">",
"      French LK, Hendrickson RG, Horowitz BZ. Amanita phalloides poisoning. Clin Toxicol (Phila) 2011; 49:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/25\">",
"      Michelot D, Toth B. Poisoning by Gyromitra esculenta--a review. J Appl Toxicol 1991; 11:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/26\">",
"      Leathem AM, Dorran TJ. Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. CJEM 2007; 9:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/27\">",
"      Frank H, Zilker T, Kirchmair M, et al. Acute renal failure by ingestion of Cortinarius species confounded with psychoactive mushrooms: a case series and literature survey. Clin Nephrol 2009; 71:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/28\">",
"      Mount P, Harris G, Sinclair R, et al. Acute renal failure following ingestion of wild mushrooms. Intern Med J 2002; 32:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/29\">",
"      Rohrmoser M, Kirchmair M, Feifel E, et al. Orellanine poisoning: rapid detection of the fungal toxin in renal biopsy material. J Toxicol Clin Toxicol 1997; 35:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/30\">",
"      Danel VC, Saviuc PF, Garon D. Main features of Cortinarius spp. poisoning: a literature review. Toxicon 2001; 39:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/31\">",
"      Bedry R, Baudrimont I, Deffieux G, et al. Wild-mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med 2001; 345:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/32\">",
"      Chodorowski Z, Waldman W, Sein Anand J. Acute poisoning with Tricholoma equestre. Przegl Lek 2002; 59:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/33\">",
"      Anand JS, Chwaluk P, Sut M. Acute poisoning with Tricholoma equestre. Przegl Lek 2009; 66:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/34\">",
"      Minami T, Matsumura S, Nishizawa M, et al. Acute and late effects on induction of allodynia by acromelic acid, a mushroom poison related structurally to kainic acid. Br J Pharmacol 2004; 142:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/35\">",
"      Gejyo F, Homma N, Higuchi N, et al. A novel type of encephalopathy associated with mushroom Sugihiratake ingestion in patients with chronic kidney diseases. Kidney Int 2005; 68:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/36\">",
"      Kraft J, Bauer S, Keilhoff G, et al. Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid, a toxic constituent of the mushroom Hapalopilus rutilans, in rats and humans. Arch Toxicol 1998; 72:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/37\">",
"      Olesen LL. [Poisoning with the brown roll-rim mushroom, Paxillus involutus]. Ugeskr Laeger 1991; 153:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/38\">",
"      Winkelmann M, Borchard F, Stangel W, Grabensee B. [Fatal immunohaemolytic anaemia after eating the mushroom Paxillus involutus (author's transl)]. Dtsch Med Wochenschr 1982; 107:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/39\">",
"      Winkelmann M, Stangel W, Schedel I, Grabensee B. Severe hemolysis caused by antibodies against the mushroom Paxillus involutus and its therapy by plasma exchange. Klin Wochenschr 1986; 64:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/40\">",
"      Strand RD, Neuhauser EB, Sornberger CF. Lycoperdonosis. N Engl J Med 1967; 277:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/41\">",
"      Centers for Disease Control and Prevention (CDC). Respiratory illness associated with inhalation of mushroom spores--Wisconsin, 1994. MMWR Morb Mortal Wkly Rep 1994; 43:525.",
"     </a>",
"    </li>",
"    <li>",
"     Baier, J. Mushrooms and Toadstools: An Illustrated Guide, JG Press, North Dighton, MA 1995. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/43\">",
"      Fischbein CB, Mueller GM, Leacock PR, et al. Digital imaging: a promising tool for mushroom identification. Acad Emerg Med 2003; 10:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/44\">",
"      Butera R, Locatelli C, Coccini T, Manzo L. Diagnostic accuracy of urinary amanitin in suspected mushroom poisoning: a pilot study. J Toxicol Clin Toxicol 2004; 42:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/45\">",
"      Parant F, Peltier L, Lardet G, et al. [Phalloidin syndrome: role of Elisa-based assay for the detection of alpha- and gamma-amanitins in urine. Preliminary results]. Acta Clin Belg Suppl 2006; :11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/46\">",
"      Spiteller P, Spiteller M, Steglich W. Occurrence of the fungal toxin orellanine as a diglucoside and investigation of its biosynthesis. Angew Chem Int Ed Engl 2003; 42:2864.",
"     </a>",
"    </li>",
"    <li>",
"     Sarwar M, McDonald J.  A rapid extraction and GC/MS methodology for the identification of psilocin in mushroom/chocolate concoctions. Microgram Journal 2003; 1:177. file://www.justice.gov/dea/programs/forensicsci/microgram/journal071203/mj071203_pg4.html.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/48\">",
"      Epis S, Matinato C, Gentili G, et al. Molecular detection of poisonous mushrooms in different matrices. Mycologia 2010; 102:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/49\">",
"      Enjalbert F, Rapior S, Nouguier-Soul&eacute; J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 2002; 40:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/50\">",
"      Simmons DM. The Meixner test for amatoxins in mushrooms. Clin Toxicol 1980; 16:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/47/1786/abstract/51\">",
"      Beuhler M, Lee DC, Gerkin R. The Meixner test in the detection of alpha-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines. Ann Emerg Med 2004; 44:114.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16135 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-0E3ADE63EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1786=[""].join("\n");
var outline_f1_47_1786=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21619236\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21617115\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21617122\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21619983\">",
"      MUSHROOM POISONING SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21621437\">",
"      Acute symptom onset (&lt;6 hours after ingestion)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21621536\">",
"      - Acute gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21621724\">",
"      - Hallucinations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21621879\">",
"      - CNS excitation and depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21622033\">",
"      - Cholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21622148\">",
"      - Disulfuram-like reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21621445\">",
"      Delayed symptom onset (&gt;6 hours after ingestion)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H507571\">",
"      - Delayed gastroenteritis and renal failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21619990\">",
"      - Delayed gastroenteritis and liver toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21619997\">",
"      - Delayed gastroenteritis, seizures, and liver toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620032\">",
"      - Delayed renal failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620046\">",
"      - Delayed rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21620060\">",
"      Rare manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620067\">",
"      - Erythromelalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620074\">",
"      - Delayed encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620081\">",
"      - Immune-mediated hemolytic anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21620088\">",
"      - Allergic bronchioalveolitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21617129\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21617136\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21617143\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21617150\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21617157\">",
"      - Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21617164\">",
"      Mushroom identification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21623937\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21619229\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21619236\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/16135\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/16135|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/16/8453\" title=\"picture 1\">",
"      Little brown mushrooms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/19/12592\" title=\"picture 2\">",
"      Nontoxic mushroom ingestion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/63/7152\" title=\"picture 3\">",
"      Amanita phalloides-Death cap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/35/17974\" title=\"picture 4\">",
"      Amanita bisporigera-Destroying angel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/32/32265\" title=\"picture 5\">",
"      Gyromitra esculenta - false morel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/28/13768\" title=\"picture 6\">",
"      Amanita muscaria variant-fly agaric mushroom",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/16/26886\" title=\"picture 7\">",
"      Inky cap mushroom",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/14/35041\" title=\"picture 8\">",
"      Mushroom spore print",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/16135|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/28/11727\" title=\"table 1\">",
"      Mushroom poisoning syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36759?source=related_link\">",
"      Amanita smithiana mushroom poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10698?source=related_link\">",
"      Amatoxin-containing mushroom poisoning including ingestion of Amanita phalloides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14232?source=related_link\">",
"      Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=related_link\">",
"      Differential diagnosis of microbial foodborne disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43753?source=related_link\">",
"      Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42615?source=related_link\">",
"      Management of mushroom poisoning",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_47_1787="Precursors of normal speech";
var content_f1_47_1787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Precursors of normal speech and language development in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        The child should be able to:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Play meaningfully with toys",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interact appropriately with others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Demonstrate the ability to understand the world around him or her",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Imitate body gestures, movements of the articulators, sounds, syllables",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Comprehend simple verbal directions",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1787=[""].join("\n");
var outline_f1_47_1787=null;
var title_f1_47_1788="ACC AHA HRS prevent tachy";
var content_f1_47_1788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA/HRS guideline summary: Indications for pacing to prevent tachycardia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class I - There is evidence and/or general agreement that pacing should be used to prevent tachycardia in the following setting:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &bull;  Sustained pause-dependent ventricular tachycardia (VT), with or without QT prolongation. (Level of Evidence: C)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIa - The weight of evidence or opinion is in favor of the usefulness of pacing to prevent tachycardia in the following setting:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &bull;  High-risk patients with congenital long QT syndrome. (Level of Evidence: C)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIb - The weight of evidence or opinion is less well established for the usefulness of pacing to prevent tachycardia in the following setting:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &bull;  Prevention of symptomatic, drug-refractory, recurrent atrial fibrillation in patients with coexisting sinus node dysfunction. (Level of Evidence: B)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class III - There is evidence and/or general agreement that pacing to prevent tachycardia is not useful in the following settings:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &bull;  Frequent or complex ventricular ectopic activity without sustained VT in the absence of the long QT syndrome. (Level of Evidence: C)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &bull;  Torsade de pointes VT due to reversible causes. (Level of Evidence: A)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Epstein, AE, DiMarco, JP, Ellenbogen, KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1788=[""].join("\n");
var outline_f1_47_1788=null;
var title_f1_47_1789="Linkage one pedigree";
var content_f1_47_1789=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Linkage in one pedigree",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 275px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    All affected subjects (denoted as shaded) have a presumed disease genotype of Dd (ie, assumption of an autosomal dominant trait). The genotyped marker (with alleles 1, 2, or 3) appears to be linked in this pedigree with the disease locus, as all affected subjects harbor the 1 allele - this marker tracks with disease status.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1789=[""].join("\n");
var outline_f1_47_1789=null;
var title_f1_47_1790="Etiology of easy bruising";
var content_f1_47_1790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of easy bruising and characteristic signs and symptoms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Etiology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Characteristic signs and symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        A. Disorders of blood vessels and surrounding tissue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Idiopathic*",
"       </td>",
"       <td>",
"        Bruises typically found on upper arms and legs, more common in women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Physical abuse*",
"       </td>",
"       <td>",
"        Bruises that pattern after objects, in nonmobile subjects, a history inconsistent with patient's injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aging (senile purpura)*",
"       </td>",
"       <td>",
"        Dark ecchymosis in aged, thin skin; typically over extensor surfaces of forearms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glucocorticoids*",
"       </td>",
"       <td>",
"        Patients at risk with long term use (eg, polymyalgia rheumatica)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcohol abuse*",
"       </td>",
"       <td>",
"        History of heavy alcohol intake; signs of cirrhotic liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wasting, malnutrition*",
"       </td>",
"       <td>",
"        Dietary history, cachetic on examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vitamin C deficiency (scurvy)",
"       </td>",
"       <td>",
"        Dietary history; dental deterioration, impaired wound healing, coiled hairs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypercortisolism, Cushing's syndrome",
"       </td>",
"       <td>",
"        Supraclavicular fat pads, skin atrophy, wide purplish striae, and proximal muscle weakness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ehlers-Danlos syndrome",
"       </td>",
"       <td>",
"        Hypermobility of joints; skin hyperelasticity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pseudoxanthoma elasticum",
"       </td>",
"       <td>",
"        Characteristic skin findings: 2 to 5 mm yellow to orange papules",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amyloidosis",
"       </td>",
"       <td>",
"        Multiple manifestations depending on type of amyloidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hereditary hemorrhagic telangiectasia",
"       </td>",
"       <td>",
"        Mucocutaneous telangiectasias and gastrointestinal arteriovenous malformations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Marfan syndrome",
"       </td>",
"       <td>",
"        Tall and thin; stretch marks; pectus excavatum; mitral valve prolapse; dilated aortic root",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Osteogenesis imperfecta",
"       </td>",
"       <td>",
"        Short stature, multiple fractures, increased laxity of ligaments and skin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Connective tissue disease, cryoglobulinemia, or vasculitis (eg, Henoch Schonlein purpura)",
"       </td>",
"       <td>",
"        Systemic symptoms, presence of palpable purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        B. Platelet abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Drugs*",
"       </td>",
"       <td>",
"        Possible temporal relationship to symptom onset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Renal disease*",
"       </td>",
"       <td>",
"        Decreased glomerular filtration rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic illness* (liver disease, myeloproliferative disorder, infection)",
"       </td>",
"       <td>",
"        Constitutional symptoms, lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Von Willebrand disease* (VWF)",
"       </td>",
"       <td>",
"        Reduced VWF antigen and ristocetin cofactor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Leukemia",
"       </td>",
"       <td>",
"        Abnormal complete blood count, peripheral smear, and bone marrow biopsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphoid malignancy",
"       </td>",
"       <td>",
"        Lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        May-Hegglin anomaly",
"       </td>",
"       <td>",
"        Autosomal dominant trait characterized by mild bruising/bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thrombocytopenia Absent Radius (TAR) syndrome",
"       </td>",
"       <td>",
"        Autosomal recessive disorder with severe thrombocytopenia and absent radii bones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Storage pool disease",
"       </td>",
"       <td>",
"        Joint or soft tissue bleeding, males affected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bernard-Soulier syndrome",
"       </td>",
"       <td>",
"        Autosomal recessive disorder leading to absence of platelet glycoprotein Ib-IX-V, circulating giant platelets, immediate bleeding (not delayed bleeding as in coagulation disorders)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glanzmann thrombasthenia",
"       </td>",
"       <td>",
"        Autosomal recessive disorder leading to absence of platelet glycoprotein IIb/IIIa, circulating giant platelets; no platelet clumping on platelet aggregation studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gaucher disease",
"       </td>",
"       <td>",
"        Autosomal recessive disorder presenting in childhood with varying symptoms depending on type 1, 2, 3a, 3b, or 3c",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wiskott-Aldrich syndrome",
"       </td>",
"       <td>",
"        X-linked disorder characterized by hemorrhagic diathesis, recurrent infection, extensive eczema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Autoimmune disorders",
"       </td>",
"       <td>",
"        Multi-system disease including joint inflammation, abnormal antibody testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myeloproliferative disorders",
"       </td>",
"       <td>",
"        Abnormal bone marrow biopsy with increased platelets and positive for JAK 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        C. Coagulation protein disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Liver disease*",
"       </td>",
"       <td>",
"        History of alcohol abuse, modestly elevated liver function tests, hepatomegaly, ascites, stigmata of chronic liver disease (spider angiomata, palmar erythema, gynecomastia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vitamin K deficiency, warfarin therapy*",
"       </td>",
"       <td>",
"        Antibiotic administration, poor nutritional status, vitamin K binding drugs (cholestyramine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemophilia (factor VIII, IX, deficiency)",
"       </td>",
"       <td>",
"        Males affected, family history, delayed bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Circulating anticoagulant or inhibitor",
"       </td>",
"       <td>",
"        Similar to hemophilia but onset is sudden and no patient or family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dysfibrinogenemia",
"       </td>",
"       <td>",
"        Diagnosis of exclusion, identified with fibrinogen tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plasminogen activator deficiency or inhibitor",
"       </td>",
"       <td>",
"        Delayed bleeding",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Denotes frequently seen cause.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1790=[""].join("\n");
var outline_f1_47_1790=null;
var title_f1_47_1791="Winging of scapula";
var content_f1_47_1791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Winging of the scapula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 198px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Winging of the left scapula is noted in this patient with long thoracic nerve entrapment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert P Sheon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_47_1791=[""].join("\n");
var outline_f1_47_1791=null;
